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Abstract
Adipose tissue plays a critical role in defending against metabolic disease by sequestering excess
calories and preventing their harmful deposition in ectopic locations. Healthy expansion of adipose
occurs via hyperplastic growth, the differentiation of adipocyte progenitor cells (APCs) into new fat cells.
The capacity for hyperplastic expansion depends on the fundamental properties of APCs. Prior studies of
APCs used narrow identification methods and did not fully characterize the identity and nature of APCs.
We used single-cell RNA sequencing to identify distinct types of progenitor cells in murine and human
adipose tissue. Functional assessments of these cell types in vitro and in vivo define a mesenchymal cell
hierarchy involved in adipocyte formation. We identified several distinct mesenchymal cell types in murine
and human adipose. Dipeptidyl peptidase–4–expressing (DPP4+) cells are highly proliferative and
multipotent progenitors that are relatively resistant to differentiation into adipocytes. Intercellular
adhesion molecule–1–expressing (ICAM1+) cells are committed preadipocytes that express Pparg and
are poised to differentiate into mature adipocytes with minimal stimulation. CD142+ cells represent a
distinct adipogenic population in murine subcutaneous adipose that shares many properties with ICAM1+
preadipocytes. Computational cell trajectory analyses and in vivo transplantation studies showed that
DPP4+ progenitors give rise to both ICAM1+ and CD142+ preadipocytes before differentiation into mature
adipocytes. DPP4+ cells depend on transforming growth factor–b signaling to maintain their progenitor
identity. Obesity and insulin resistance lead to a depletion of DPP4+ progenitors and a reduction in the
adipogenic differentiation competency of APCs in visceral white adipose tissue. Single-cell analysis of
human subcutaneous adipose tissue revealed distinct DPP4+ and ICAM1+ populations that displayed
functional properties similar to those of the analogous mouse populations. Histological examination of
murine subcutaneous adipose tissue showed that ICAM1+ preadipocytes are intercalated between
mature adipocytes. The DPP4+ progenitor cells are localized in a previously uncharacterized fibrous niche
which surrounds adipose depots, which we term the reticular interstitium. Overall, our studies define the
developmental hierarchy of adipose progenitors, describe a new anatomic niche, and lay the groundwork
for future therapies targeting one or more of these APC populations.
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ABSTRACT
IDENTIFICATION OF A MESENCHYMAL PROGENITOR CELL HIERARCHY IN
ADIPOSE TISSUE
Alexander P. Sakers
Patrick Seale, Ph.D.
Adipose tissue plays a critical role in defending against metabolic disease by
sequestering excess calories and preventing their harmful deposition in ectopic locations.
Healthy expansion of adipose occurs via hyperplastic growth, the differentiation of
adipocyte progenitor cells (APCs) into new fat cells. The capacity for hyperplastic
expansion depends on the fundamental properties of APCs. Prior studies of APCs used
narrow identification methods and did not fully characterize the identity and nature of
APCs. We used single-cell RNA sequencing to identify distinct types of progenitor cells
in murine and human adipose tissue. Functional assessments of these cell types in vitro
and in vivo define a mesenchymal cell hierarchy involved in adipocyte formation. We
identified several distinct mesenchymal cell types in murine and human adipose.
Dipeptidyl peptidase–4–expressing (DPP4+) cells are highly proliferative and
multipotent progenitors that are relatively resistant to differentiation into adipocytes.
Intercellular

adhesion

molecule–1–expressing

(ICAM1+)

cells

are

committed

preadipocytes that express Pparg and are poised to differentiate into mature adipocytes
with minimal stimulation. CD142+ cells represent a distinct adipogenic population in
murine subcutaneous adipose that shares many properties with ICAM1+ preadipocytes.
Computational cell trajectory analyses and in vivo transplantation studies showed that
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DPP4+ progenitors give rise to both ICAM1+ and CD142+ preadipocytes before
differentiation into mature adipocytes. DPP4+ cells depend on transforming growth
factor–b signaling to maintain their progenitor identity. Obesity and insulin resistance
lead to a depletion of DPP4+ progenitors and a reduction in the adipogenic differentiation
competency of APCs in visceral white adipose tissue. Single-cell analysis of human
subcutaneous adipose tissue revealed distinct DPP4+ and ICAM1+ populations that
displayed functional properties similar to those of the analogous mouse populations.
Histological examination of murine subcutaneous adipose tissue showed that ICAM1+
preadipocytes are intercalated between mature adipocytes. The DPP4+ progenitor cells
are localized in a previously uncharacterized fibrous niche which surrounds adipose
depots, which we term the reticular interstitium. Overall, our studies define the
developmental hierarchy of adipose progenitors, describe a new anatomic niche, and lay
the groundwork for future therapies targeting one or more of these APC populations.
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PREFACE
Much of the work presented in this thesis was generated in collaboration with
another member of the Seale laboratory, David Merrick MD, PhD. David Merrick,
studying neonatal fat, and I, investigating adult fat, converged on similar lines of inquiry
and decided to combine our efforts. Most of the experiments were conceived, performed,
and analyzed collaboratively, with each of us participating in some component of nearly
every experiment. Data visualizations, interpretations, and manuscript writing were
performed jointly by me, David Merrick, and Patrick Seale. For the sake of clarity and
proper attribution I have highlighted our relative contributions below:
Chapter 1 contains only my individual work.
In Chapter 2, generation of the adult mouse scRNA seq data, adipogenesis and
proliferation assays, and bulk RNA sequencing data were performed by me. David
Merrick performed the osteogenesis assays, transplantation studies, and generated
visualizations for the single cell data. Large portions of the text in this chapter derive
from our co-authored manuscript; notably, I have made significant additions for
thoroughness and clarity.
In Chapter 3, the diet induced obesity model was characterized jointly by David
Merrick and me; he performed the GTT and flow sorting of cells, while I performed the
adipogenesis and proliferation assays. Likewise, both David and I performed FACS for
progenitor cells from the EWAT, AxWAT, and BAT. I performed all of the in vitro
assays. David generated the visualizations for the FACS data. The bulk RNA sequencing
and FACS analysis of the effects of cold exposure on progenitor cell populations was my
xi

individual effort. Most of the text in this section is my individual work. Portions of the
results section, describing the diet induced obesity model and the analysis of EWAT,
AxWAT, and BAT, are derived from our co-authored manuscript.
In Chapter 4, the development of the FACS sorting strategy for humans and in
vitro characterization of human cells were performed by me. David Merrick analyzed and
created the visualizations of the human single cell data. Some portion of the text in the
results section of this chapter derive from our co-authored manuscript.
In Chapter 5, some of the text in the summary and in the section comparing our
results to those of other groups is adapted from our co-authored manuscript.
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Chapter 1: Introduction
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1.1

Adipose Tissue: White, Beige, and Brown
Adipose tissue, or more colloquially fat tissue, is defined by the presence of

specialized lipid storing cells called adipocytes (Rosen & Spiegelman, 2014). Mammals
have three distinct types of adipose tissue – white, beige, and brown – each of which
serves myriad roles in the regulation of systemic energy metabolism (Cannon &
Nedergaard, 2004; Peirce, Carobbio, & Vidal-Puig, 2014). White adipose tissue (WAT)
is a lipid storage and endocrine organ, while beige and brown adipose tissue are
specialized thermoregulatory organs capable of expending nutritional energy to generate
heat (Cannon & Nedergaard, 2004; Lidell et al., 2013; Rosenwald & Wolfrum, 2014).
Due to the epidemic of obesity, a condition characterized by excessive body fat, there is
immense interest in the mechanisms of adipose tissue development, function, and
dysfunction (González-Muniesa et al., 2017; Rosen & Spiegelman, 2014). Targeting
adipose to promote metabolically healthy storage of excess nutrients or to enhance energy
expenditure represents a promising therapeutic approach (Ghaben & Scherer, 2019;
Wernstedt Asterholm et al., 2014; Yoneshiro et al., 2013).

White adipose tissue
White adipose tissue is the most abundant form of fat in humans and mice, and is
found in almost every area of the body (Zwick, Guerrero-Juarez, Horsley, & Plikus,
2018). The defining feature of white adipose tissue is the presence of white adipocytes,
which have a single large lipid droplet, relatively few mitochondria, and a nucleus
situated at the periphery of the cell. White adipocytes are found in places as superficial as
2

the dermis, where they function in wound healing and hair follicle cycling, to places as
deep the ovaries, where they provide mechanical cushioning (Chambon et al., 2017;
Zwick et al., 2018). The vast majority of white adipose tissue is located subcutaneously
and functions as a dynamic store of nutritional energy to solve a fundamental problem
that all living organisms encounter: the fact that access to food is sporadic (Ottaviani,
Malagoli, & Franceschi, 2011; Pond, 2012).
In normal physiology, WAT functions as a buffer against the oscillations in
calorie availability over time. During times of nutritional excess, it stores chemical
energy in the form of lipid droplets (Czech, 2017). During times of nutritional
deprivation, it releases this energy to the rest of the organism by exporting lipid in the
form of free fatty acids (lipolysis) (Morigny, Houssier, Mouisel, & Langin, 2016). These
two processes ensure that other body tissues always have access to an adequate but not
excessive level of nutrients. Although only vertebrates have adipose tissue, the capacity
to safely store and efficiently release chemical energy is so important that all eukaryotes
have evolved a mechanism to handle lipid droplets (Festuccia & Laplante, 2005;
Ottaviani et al., 2011).
The major signal for nutrient uptake into adipocytes is elevated circulating levels
of the hormone insulin (Rorsman & Braun, 2013). Insulin is secreted by pancreatic βcells in response to increased levels of glucose and fatty acids, a proxy for nutrient
abundance (Rorsman & Braun, 2013). Insulin binds to the insulin receptor, a receptor
tyrosine kinase, on the extracellular membrane of adipocytes and other insulin responsive
tissues (De Meyts, 2000). Through a complex signal transduction cascade, the binding of
insulin activates AKT (protein kinase B) via phosphorylation (Kohn, Takeuchi, & Roth,
3

1996). Activated AKT stimulates uptake of glucose via the translocation of GLUT4 to the
cell surface, and also suppresses lipolysis and stimulates de novo lipogenesis (Boucher J,
Kleinridders A, 2014; Shepherd et al., 1993). Insulin signaling is critical for the de novo
differentiation and maintenance of adipocytes (Nakae et al., 2003; Sakaguchi et al., 2017;
Shearin, Monks, Seale, & Birnbaum, 2016). Numerous studies have shown that genetic
deletion of the insulin receptor or downstream effectors such as GLUT4 or the various
AKT isoforms in adipose tissue can cause insulin resistance and varying degrees of
lipodystrophy (Abel et al., 2001; Bae, Cho, Mu, & Birnbaum, 2003; Shearin et al., 2016).
Lipolysis is the process of hydrolyzing triacylglycerols, the primary constituent of
adipocyte lipid droplets, into their component parts of glycerol and free fatty acids
(Morigny et al., 2016). Lipolysis in adipocytes is primarily induced by signaling through
β-adrenergic receptors; these G-protein coupled receptors signal through heterotrimeric
Gs to activate adenylyl cyclase (Collins, 2012). Activated adenylyl cyclase raises
intracellular levels of cyclic adenosine monophosphate (cAMP) which in turn activates
the protein kinase a (PKA) and p38/MAPK signaling pathway (Collins, 2012). Activated
PKA phosphorylates several components of the lipolytic machinery to enable lipolysis;
these include activating phosphorylation on hormone sensitive lipase (HSL) and
inhibitory phosphorylation on the lipid droplet protein perilipin (Collins, 2012; Tansey,
Sztalryd, Hlavin, Kimmel, & Londos, 2004). Combined, these actions lead to release of
free fatty acids and glycerol from WAT into the circulation for use by other organs.

4

Endocrine functions of white adipose tissue
White adipose tissue is recognized as an endocrine organ as it secretes numerous
hormones and other factors, collectively termed adipokines (Musi & Guardado-Mendoza,
2014; Ouchi, Parker, Lugus, & Walsh, 2011). Adipokines serve numerous functions, but
in general signal about the state of WAT to the central nervous system and other tissues
(Musi & Guardado-Mendoza, 2014). Hundreds of adipokines have been described with
roles in insulin sensitization ( ex. adiponectin), insulin resistance (ex. resistin, RBP4,
lipocalin), inflammation (ex. TNF, IL-6, IL-18), and communication of nutrient levels
(ex. leptin) (Ouchi et al., 2011). The most well-studied adipokine is leptin. Leptin is
secreted by adipocytes and signals in the hypothalamus to communicate information to
the brain about the current mass of adipose tissue (Zhang Y et al., 1994). High levels of
leptin indicate that the adipose tissue is replete with nutrients while low levels signal a
deficiency. Consistent with this role, rare loss of function mutations in leptin (in mice,
ob/ob) or the leptin receptor (in mice, db/db) drive some of the most severe forms
monogenic obesity (Clément et al., 1998; Ozata, Ozdemir, & Licinio, 1999).

Thermogenic brown and beige adipose tissue
Brown and beige adipocytes represent a relatively small proportion of total
adipose tissue but exert an outsized metabolic impact due to their ability to engage in
thermogenesis. Thermogenic adipocytes have the capacity for uncoupled respiration, a
process in which nutrients are metabolized for the purpose of generating heat
(Nedergaard et al., 2001). These tissues help mammals defend their body temperature in
5

cold environments (Cannon & Nedergaard, 2004). The discovery that adult humans have
functional thermogenic fat promoted a surge of interest in brown and beige adipose tissue
(Cypess et al., 2009; Ouellet et al., 2011). Since these tissues are specialized to burn
excess energy, augmenting their activity holds promise as a potential anti-obesity therapy
(Chondronikola et al., 2014, 2016; Yoneshiro et al., 2013).
Brown and beige adipocytes display functional similarities due to shared gene
expression patterns and regulatory circuits. Both are characterized by small multilocular
lipid droplets, high mitochondrial density, and the expression of Uncoupling Protein 1
(UCP1) (Cannon & Nedergaard, 2004; Jespersen et al., 2013). UCP1 disengages nutrient
catabolism from ATP synthesis by dissipating the proton gradient in the inner
mitochondrial membrane. Through this inefficiency, UCP1 enables brown/beige
adipocytes to metabolize nutrients to generate heat (Nedergaard et al., 2001).
Although brown and beige adipocytes show functional similarities, they develop
from distinct developmental lineages. Brown adipocytes develop during embryogenesis
from a shared lineage with muscle and are found in dedicated, relatively homogeneous
depots of brown adipose tissue (BAT) (Seale et al., 2008, 2007). Beige adipocytes
develop in response to cold or beta-adrenergic stimulation within white adipose depots
(Young, Arch, & Ashwell, 1984). Several studies suggest that the thermogenic
adipocytes found in adult humans are more similar to mouse beige adipocytes than to
classical mouse brown adipocytes (Jespersen et al., 2013; Lidell et al., 2013; Sharp et al.,
2012). Therefore, it is critical to determine the regulatory circuits controlling and the
cellular origins of beige adipose tissue. The precursor populations responsible for the
development of beige adipose tissue will be discussed in later in this introduction.
6

1.2

Adipocyte Differentiation
Adipocyte differentiation is the process by which mesenchymal progenitor cells

commit to the adipocyte lineage (commitment) and acquire the morphological and
transcriptional features of mature adipocytes (terminal differentiation) (Cristancho &
Lazar, 2011). Much of what we know about these processes comes from in vitro models
of adipogenesis using primary cells or the highly adipogenic immortalized fibroblast
3T3-L1 cell line. The most commonly used primary cell model involves isolating cells
from the stromal vascular fraction (SVF) of adipose tissue. SVF is isolated by
enzymatically digesting adipose into a single cell suspension followed by centrifugation
to separate mature adipocytes (which float) from the SVF (the pelleted cells). The SVF is
a complicated mixture of cells, many of which contain in vitro adipogenic potential
(Bjorntorp et al., 1978).
A full understanding of adipocyte commitment has been hampered by the lack of
in vivo marks for cells restricted to the adipocyte lineage (i.e. committed preadipocytes).
Despite this, work has indicated that the commitment process likely involves the
integration of several pro and anti adipogenic growth factor signals. Anti adipogenic
signals include: cannonical and non-cannonical WNT pathways (especially WNT5,
WNT6, WNT10a, and WNT10b) (Cawthorn et al., 2012; Cristancho & Lazar, 2011),
transforming growth factor beta (TGFβ) (Ignotz & Massagut, 1985), and hedgehog
signaling (Suh et al., 2006). Pro adipogenic signals include: Bone Morphogenic Protein
(BMP) signaling (especially BMP2 and BMP4) (Cristancho & Lazar, 2011; Q.-Q. Tang,
Otto, & Lane, 2004) and extracellular matrix composition (Cristancho & Lazar, 2011).
The process of terminal differentiation involves the coordinated action of several
7

transcription factors, most notably Peroxisome Proliferator Activated Receptor-γ
(PPARγ) and CCAAT/ enhancer binding proteins (C/EBP) family members, C/EBPα,
C/EBPβ, and C/EBPδ (Chawla & Lazar, 1994; Tontonoz, Hu, & Spiegelman, 1994). The
standard in vitro adipogenic cocktail includes glucocorticoids, insulin, and 3-isobutyl-1methylxanthine (which raises intracellular levels of cAMP). Upon treatment with this
cocktail, there is a transient induction of C/EBPβ and C/EBPδ, which induce the
expression of C/EBPα and PPARγ. C/EBPα and PPARγ engage in a feed forward loop,
inducing the expression of each other, and driving the transcription of mature adipocyte
identity genes (Cristancho & Lazar, 2011). Notably PPARγ is always necessary for
adipogenesis and in many systems is sufficient (Cristancho & Lazar, 2011). Thus, PPARγ
is often called the master regulator of adipogenesis. Overall, the process of adipocyte
differentiation takes about 8 days in culture but may be shorter in vivo (Q. A. Wang, Tao,
Gupta, & Scherer, 2013).

1.3

Adipose Tissue Expansion: Where and How?
White adipose tissue exhibits a remarkable ability to expand and contract. In

humans, body fat percentages can range dramatically: from normal levels of 10-20% in
men and 15-30% in women, to lows of below 5% in patients with cachexia, and highs of
70% in people with severe obesity (Imboden, Swartz, Finch, Harber, & Kaminsky, 2017;
L. B. Salans, Cushman, & Weismann, 1973). No other tissue in the body exhibits such
extreme flexibility (J. H. Stern & Scherer, 2015). Notably, not all adipose tissue
expansion is created equal. The site of expansion, whether in visceral or subcutaneous
8

depots, and the method, whether hyperplastic or hypertrophic, have profound impacts on
metabolic health (Ghaben & Scherer, 2019; Samuel & Shulman, 2016). The following
sections will more closely explore the topic of metabolic health and the concept of
healthy versus unhealthy growth of adipose tissue.
Metabolic health: obesity and insulin resistance
By 2025 it is estimated that nearly 20% of all adults globally will be obese (Di
Cesare et al., 2016). Obesity is defined as body weight out of proportion to height and is
typically measured as [kg/m2] using a scale called body mass index (BMI). A score of
over 25 indicates overweight while a score over 30 indicates obesity (Karpe & Pinnick,
2015). At the most basic level, obesity is a disorder of energy balance. A chronic excess
of calorie intake relative to calorie expenditure leads to weight gain, predominantly in the
form of adipose tissue (González-Muniesa et al., 2017). The rapidly increasing
prevalence of obesity presents a significant challenge to healthcare systems due to its
causal role in the development of type II diabetes, cardiovascular disease, and other
illnesses (Bhaskaran, dos-Santos-Silva, Leon, Douglas, & Smeeth, 2018; Blüher, 2019;
Di Angelantonio et al., 2016).
Obesity is associated with a number of comorbid metabolic pathologies, which
together are often called “the metabolic syndrome” (Lanktree & Hegele, 2017). They are:
high blood glucose, high blood triglycerides, low HDL cholesterol, hypertension, and
central (abdominal) obesity. These findings correlate strongly with the related
phenomenon of insulin resistance, a condition in which cells and tissues show reduced
responsiveness to insulin. (Samuel & Shulman, 2012). At the cellular level, insulin
9

resistance involves reduced signaling through the Insulin Receptor-PI3K-AKT pathway
(Odegaard & Chawla, 2013). In adipocytes, it manifests as reduced uptake of glucose per
unit of insulin and as a failure to suppress lipolysis (Koren et al., 2015). Systemically,
insulin resistance is characterized by higher blood glucose and insulin levels. In animal
models, insulin resistance is often assessed by demonstrating reduced blood glucose
clearance in response to a bolus of glucose or insulin.
The presence of insulin resistance or the metabolic syndrome is a risk factor for
the development of metabolic disease (Vancampfort et al., 2016). Indeed, people with the
metabolic syndrome have double the risk for developing cardiovascular disease and five
times the risk for developing type II diabetes over a 5-10 year period (Lanktree & Hegele,
2017). Because of these tight associations with disease, the term “metabolic health”, is
often used as a shorthand to denote the absence of insulin resistance or the metabolic
syndrome.
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Figure 1.1: Metabolic consequences of adipose tissue expansion.

Adipose tissue may expand in one of two ways, by hypertrophy or by hyperplasia, and in
one of two anatomic locations, subcutaneous or visceral. Expansion through hypertrophy,
growth in the size of preexisting fat cells, is associated with tissue dysfunction and
predisposition to metabolic disease. Expansion via hyperplasia, growth in the number of
fat cells through de novo differentiation of progenitors, is associated with protection from
metabolic disease. Similarly, expansion in visceral compartments is metabolically
detrimental but expansion in subcutaneous compartments is protective. The balance of
which form and location of expansion predominates may depend on properties intrinsic to
the tissue resident adipocyte precursors.
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Where: subcutaneous versus visceral adipose tissue expansion
The most commonly employed distinction between modes of adipose tissue
expansion is based on whether the excess fat is located in subcutaneous or visceral
anatomical compartments (Figure 1.1). This categorization has gained widespread use
due to the strong association of increased visceral adipose tissue mass with the
development of the metabolic disease (Tchernof & Després, 2013). In contrast,
subcutaneous adipose tissue expansion, while not beneficial per se, is viewed as
protective in the setting of obesity (Karastergiou & Fried, 2013).
Visceral adipose tissue depots are those within the peritoneal cavity. In humans,
visceral fat is found in the omental, mesenteric, epicardial, and (in females) gonadal
depots. Subcutaneous depots are located more superficially, just beneath the skin.
Subcutaneous adipose tissue represents 80% or more of total fat mass and is present as a
continuous sheet in nearly all areas of the body (Karastergiou & Fried, 2013; M. J. Lee,
Wu, & Fried, 2013). The largest concentrations of subcutaneous fat are found in the
abdominal, gluteofemoral, and intramuscular depots (Chusyd, Wang, Huffman, & Nagy,
2016).
Mice have somewhat analogous visceral (mesenteric, perirenal, and gonadal) and
subcutaneous (inguinal and axillary) depots. Commonly, the inguinal depot is used to
model human subcutaneous fat and the gonadal depot (epididymal in male mice,
paraovarian in female mice) is used to model visceral fat (Chusyd et al., 2016). While
these models are imperfect (one notable example: murine gonadal fat drains into the
systemic circulation while human visceral fat drains into the portal circulation) they have
been useful in the field of adipose tissue biology, with results often translating from mice
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to humans (Chusyd et al., 2016; Fried, Lee, & Karastergiou, 2015).
Numerous studies have examined the effects of visceral versus subcutaneous
adiposity on overall health (Karastergiou & Fried, 2013; Tchernof & Després, 2013;
Wormser et al., 2011). They typically employ imaging for direct measurement or clinical
proxies for visceral obesity such as the waist to hip ratio (a measure of “central
adiposity”). Almost universally, increased visceral or central adiposity is associated with
a higher risk of developing cardiovascular disease or diabetes (M. J. Lee et al., 2013). In
contrast, at any given level of adiposity, those with a more subcutaneous or peripheral fat
distribution are relatively protected from metabolic disease.
Differences in the distribution of adipose tissue are often used to explain the
existence of “metabolically healthy obese” and “metabolically unhealthy normal-weight”
individuals (Cherqaoui et al., 2012; N. B. Ruderman, Schneider, & Berchtold, 1981; N.
Ruderman, Chisholm, Pi-Sunyer, & Schneider, 1998). In general, the metabolically
healthy obese have unexpectedly low levels of visceral adiposity for their body weight;
the situation is reversed in those who are metabolically unhealthy but normal weight.
Overall, the distribution of adipose tissue appears to be a key determinant of metabolic
health at normal weight and in obesity. Therefore, deciphering how to promote
subcutaneous and diminish visceral adipose tissue expansion may represent an effective
therapy for metabolic disease.
How: hypertrophic versus hyperplastic adipose tissue expansion
In addition to the location of adipose tissue growth, the mechanism by which the
tissue expands exerts a strong influence on metabolic health. Adipose tissue can expand
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in one of two ways: by hypertrophy or by hyperplasia (Figure 1.1) (J. Hirsch & Han,
1969). Hypertrophic growth occurs via the expansion in size of preexisting fat cells while
hyperplastic growth is driven by an increase in the number of fat cells via the
differentiation of adipocyte progenitors (Hepler & Gupta, 2017). Hypertrophic growth is
associated with adipose tissue inflammation, fibrosis, hypoxia, and poor metabolic health
(Hepler & Gupta, 2017). In contrast, hyperplastic growth avoids these pathologic changes
and is generally metabolically favorable.
Much of the evidence for the divergent consequences of hyperplastic versus
hypertrophic expansion comes from association studies performed in humans. Very early
work performed in the 1960’s and 1970’s examined the size and number of adipocytes in
lean and obese subjects (Bjorntorp, 1974; Jules Hirsch & Batchelor, 1976; Lester B.
Salans, Knittle, & Hirsch, 1968). A common method employed biopsies of subcutaneous
adipose tissue from numerous sites (often the triceps, abdomen, and buttocks) followed
by determination of the average adipocyte mass (μg lipid/cell) and measurement of total
body fat mass. Dividing the total fat mass by the average adipocyte mass led to estimates
of the total adipocyte number (Bjorntorp, 1974).
These studies revealed several important findings. First, obese subjects on average
have both more adipocytes and larger adipocytes than normal weight controls (Bjorntorp,
1974; L. B. Salans et al., 1973). Adipocyte size appears to increase up to the point of
moderate obesity, after which subsequent increases in fat mass are mediated by increases
in adipocyte number (Per Björntorp & Sjöström, 1971; Hirsch, J, Knittle, 1970). Notably,
there is substantial interindividual variation; at any given fat mass, people can exhibit a
more hypertrophic or more hyperplastic adipose tissue phenotype (Bjorntorp, 1974).
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Second, hypertrophic adipose tissue is associated with poor metabolic health,
including increased fasting insulin, decreased insulin sensitivity, and elevated blood
glucose levels (Per Björntorp & Sjöström, 1971; L. B. Salans et al., 1973; Lester B.
Salans et al., 1968). Indeed, several studies have indicated that fat cell size correlates
positively with markers of insulin resistance, while (when controlling for total fat mass)
fat cell number shows a negative correlation (P. Björntorp et al., 1972; Per Björntorp &
Sjöström, 1971; M. P. Stern, Olefsky, Farquhar, & Reaven, 1973).
Third, longitudinal and cross sectional studies suggested that the total number of
adipocytes increases throughout childhood before stabilizing in adulthood (Knittle,
Timmers, Ginsberg-Fellner, Brown, & Katz, 1979; Spalding et al., 2008). This third point
is worth examining further as these results have caused considerable confusion within
both the scientific community and the general population. There are two seemingly
inconsistent observations: 1) cross sectional studies imply adipocyte number is relatively
stable in adulthood and 2) these same studies show that obese adults generally have more
adipocytes than lean adults (on the order of twice as many) (Hirsch, J, Knittle, 1970;
Spalding et al., 2008). This leads to the question: when do obese adults make their extra
adipocytes?
One possibility is that, compared to lean adults, obese adults produced more
adipocytes in childhood, thus establishing a higher “set point” for their total number of
adipocytes. Consistent with this, longitudinal studies have shown that obese children
produce significantly more adipocytes during childhood than lean children (Knittle et al.,
1979). Normal weight children experience two developmental periods (from age 0-2 and
from age 13-18 years) characterized by rapid increases in adipocyte number; in contrast,
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obese children show ever increasing adipocyte numbers from age 0-18 (Knittle et al.,
1979). By the time they reach adulthood, those who were obese as children have about
twice as many fat cells as their normal weight counterparts.
Upon closer consideration however, these observations cannot explain the
increased adipocyte number seen in adult obesity. While many obese children become
obese adults, most obese adults were not obese as children (Freedman et al., 2005;
González-Muniesa et al., 2017). Thus, we are still left to ask when this expansion in fat
cell number occurred. Adults are capable of producing new adipocytes during the normal
process of adipose tissue turnover (Spalding et al., 2008). Therefore, it seems more likely
that independent of the age of onset, there is increased adipogenesis during the
development obesity. To prove this, a longitudinal study quantifying adipocyte numbers
in the transition from leanness to obesity during adulthood would be needed. To date,
such a study has not been performed.
The converse experiment, tracking adipocyte numbers during weight loss, has
been performed (J. Hirsch & Han, 1969). Weight loss induced by dietary changes or
bariatric surgery leads to a reduction in adipocyte size but a maintenance of adipocyte
number (P Björntorp et al., 1975; Häger, Sjörström, Arvidsson, Björntorp, & Smith,
1978; Kral, Bjorntorp, Schersten, & Sjostrom, 1977). Based on these studies, a model
emerges in which adult humans likely have the capacity for hyperplastic adipose tissue
expansion, albeit at a diminished level compared to children. Moreover, hyperplastic
adipose tissue expansion may function as a one-way rachet; once new adipocytes are
formed, a new set point for adipocyte number is established and maintained throughout
the lifetime of the individual. Finally, there appears to be an upper limit on adipocyte
16

size, which is reached in extreme obesity, after which increases in fat tissue volume can
only be achieved by increasing adipocyte number.

1.4

Adipose Tissue Expandability
There is considerable evidence that intervening in the natural history of obesity to

promote hyperplastic rather than hypertrophic adipose tissue expansion would be
metabolically beneficial. Support for this idea is derived from: 1) molecular analyses of
hyperplastic versus hypertrophic adipose tissue and 2) pharmacological and genetic
models of impaired or enhanced adipocyte hyperplasia.
Hypertrophic adipose tissue is dysfunctional
Hypertrophic expansion of adipose tissue is a risk factor, independent of body
mass index, for the development of the metabolic syndrome (Gustafson, Hammarstedt,
Hedjazifar, & Smith, 2013; Hardy et al., 2011). Molecular analyses of large versus small
adipocytes from within the same individual provide moderate evidence for why this is the
case. Some studies have shown that large adipocytes demonstrate higher rates of
lipolysis, enhanced recruitment of immune cells, and increased production of
inflammatory cytokines (Jernås et al., 2006; Laurencikiene et al., 2011; Xiao et al., 2016).
In addition, small adipocytes may secrete higher levels of the insulin sensitizing hormone
adiponectin (Meyer, Ciaraldi, Henry, Wittgrove, & Phillips, 2013). These observations
must be interpreted with the caveat that many of these determinations were not made on a
“per unit of adipocyte mass” basis. Therefore, it is unclear whether an equal mass of
small non-hypertrophic adipocytes would behave equivalently; this is an open question
17

for the field.
Stronger evidence comes from the analysis of WAT from insulin resistant
patients. The WAT of obese insulin resistant patients is characterized by the presence of
larger adipocytes and more fibrosis, hypoxia, and inflammation (Gustafson, Hedjazifar,
Gogg, Hammarstedt, & Smith, 2015; Hepler & Gupta, 2017; Kai Sun, Kusminski, &
Scherer, 2011). At a tissue level, this dysfunctional fat produces lower levels of insulin
sensitizing adipokines such as adiponectin and is correlated with higher levels of ectopic
lipid deposition in the muscle and liver (Klöting & Blüher, 2014). Interestingly, the WAT
of non-obese patients with insulin resistance or diabetes is also characterized by large
hypertrophic adipocytes suggesting a link between adipocyte hypertrophy (rather than
total fat mass) and metabolic dysfunction (Acosta et al., 2016).
The initiating event in the maladaptive remodeling of adipose tissue is unknown.
The prevailing model posits that a failure of angiogenesis, senescent or defective
adipocyte precursors, and inflammation cause adipose tissue to expand via adipocyte
hypertrophy rather than hyperplasia (Hepler & Gupta, 2017; Hepler, Vishvanath, &
Gupta, 2017). These hypertrophic adipocytes become hypoxic and contribute to further
tissue dysfunction by: 1) secreting high levels of inflammatory cytokines, 2) dying via
necrosis and spilling lipid in an uncontrolled manner into the tissue, and 3) producing
inappropriate amounts of collagen leading to tissue fibrosis. These processes are
continuous and mutually reinforcing, making it difficult to disentangle cause and effect.
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Pharmacologic and genetic manipulation of adipose tissue expandability
Several informative genetic and pharmacological studies have suggested that it is
not hypertrophic adipocytes per se that drive adipose tissue and systemic metabolic
dysfunction, but rather a failure of adipose tissue “expandability”. In this model,
hypertrophic adipocytes are a symptom more than a cause of dysfunctional adipose
tissue. The model posits that once adipose tissue becomes “full” and can no longer take
up excess nutrients, ectopic lipid begins to accumulate in peripheral organs leading to
metabolic decline.
The first line of evidence for this model comes from two genetic models of
healthy obesity, one characterized by extreme adipose tissue hyperplasia and the other by
extreme hypertrophy. Leptin deficient (ob/ob) mice, a model of extreme obesity, exhibit
glucose intolerance, hyperphagia, and adipose characterized by large hypertrophic
adipocytes and inflammatory macrophage infiltration (Khan et al., 2009). The metabolic
dysfunction of ob/ob mice can be ameliorated by concomitant overexpression of the
insulin sensitizing hormone adiponectin (AdiponectinTG) or by knockout of collagen 6
(col6KO) (Khan et al., 2009; Kim et al., 2007). Both models are characterized by
increased adipose tissue mass which is believed to normalize insulin sensitivity by
preventing ectopic lipid deposition in other tissues. The adipose tissue of ob/ob
AdiponectinTG mice exhibits extreme hyperplasia and contains many small adipocytes.
Interestingly, the adipose of ob/ob col6KO mice contains enormous highly hypertrophic
adipocytes.
If hypertrophic adipocytes are truly harmful, why do ob/ob col6KO mice have
less severe metabolic disease than control ob/ob mice? Collagen 6 is selectively produced
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by adipocytes compared to other cell types (Divoux et al., 2010b). It surrounds fat cells
and is responsible for the pericellular fibrosis that restrains adipocytes from expanding
past a certain size. Mice lacking collagen 6 therefore have a more permissive
extracellular matrix, allowing for unrestricted expansion. Thus, it appears that
hypertrophic adipocytes are not deleterious because they are large, but rather because
they are prevented by the ECM from getting even larger.
Further evidence comes from experiments with thiazolidinediones (TZDs) which
demonstrate that augmenting the expansion capacity of adipose tissue is beneficial in
metabolic disease. TZDs are pharmacological ligands for PPARγ, the master regulator of
adipogenesis (Chawla & Lazar, 1994; Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A.,
Wilkison, W.O., Willson, T.M., and Kliewer, 1995; Tontonoz et al., 1994). Activation of
PPARγ leads to enhanced adipocyte differentiation (hyperplasia) and, in some depots, to
enhanced expansion capacity (hypertrophy) (De Souza et al., 2001; Haliakon et al., 1997;
W. Tang, Zeve, Seo, Jo, & Graff, 2011). Although PPARγ is expressed in other cell
types, notably macrophages, muscle, and liver, the utility of TZDs as anti-diabetic drugs
is primarily believed to come from their ability to promote adipose tissue insulin
sensitivity and healthy expansion (Gavrilova et al., 2003; Hevener et al., 2003; Moore et
al., 2001; Yki-Järvinen, 2004).
Adipose tissue expansion capacity is strongly related to metabolic health.
Enhancing de novo adipocyte differentiation by overexpression of PPARγ in a subset of
progenitor cells in visceral adipose tissue improves insulin sensitivity in mice fed a high
fat diet (HFD); deletion of PPARγ in these cells demonstrates the opposite effect (Shao,
Vishvanath, et al., 2018). A similar result was observed with adipocyte specific deletion
20

of phosphate and tensin homologue (PTEN) using the following model: AdipoQrtTA-TRE-Cre
Pten

fl/fl

. PTEN is a negative regulator of adipogenesis (Morley, Xia, & Scherer, 2015).

On HFD, these mice display enhanced nutrient partitioning into the subcutaneous adipose
tissue and correspondingly enhanced insulin sensitivity. Outside of large effect size
genetic models, genome wide association studies in humans have linked common genetic
variants to reduced subcutaneous adipocyte storage capacity and to the risk of developing
insulin resistance (Chu et al., 2017; Gulati et al., 2017).
Finally, with age, adipose tissue loses some of its capacity for hyperplastic
expansion (Caso et al., 2013; Gustafson et al., 2013; Lopez-Otin, Blasco, Partridge,
Serrano, & Kroemer, 2013). This phenomenon may be due to cell-autonomous changes
in the adipocyte progenitors or due to the inhibitory effects of senescent cells and the
senescent associated secretory phenotype (SASP) (Palmer & Kirkland, 2016). Several
age associated defects in adipocyte progenitor cells have been reported, including
reduced expression of sirtuins, reduced expression of pro adipogenic transcription factors
such as C/EBP family members, and impaired proliferative capacity (Caso et al., 2013;
Karagiannides et al., 2001; Khanh et al., 2018). Furthermore, senescent progenitor cells
accumulate in the adipose tissue of aged mice and humans (Baker et al., 2016; Gustafson,
Nerstedt, & Smith, 2019). Clearance of senescent cells from the fat of old mice improves
adipogenesis in vivo (Xu et al., 2015). Likewise, suppression of the SASP in cultures of
human preadipocytes enhances adipogenic differentiation (Gustafson et al., 2019).
Combined, the effects of precursor autonomous changes and senescent cells lead to a
failure of adipogenesis in response to physiological stimuli such as HFD and cold
exposure (Khanh et al., 2018; W. Wang et al., 2019). Overall, the reduction in the
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expandability of adipose tissue with age may be a key driver of age associated metabolic
decline.

1.5

Depot Specific Mechanisms of Adipose Tissue Expansion
Several studies have examined the manner by which different adipose depots

expand during obesity in mice. The general strategy for detecting adipogenesis is as
follows: 1) Label all pre-existing mature adipocytes based on their expression of
adiponectin (AdipoQrtTA-TRE-Cre or AdiponectinCreER), plus a Cre inducible reporter like
Rosa26LacZ or Rosa26mT/mG). 2) Treat mice with high fat diet and examine the proportion
of labeled (old) versus unlabeled (new) adipocytes (Jeffery, Church, Holtrup, Colman, &
Rodeheffer, 2015; Q. A. Wang et al., 2013). In mice, expansion of the visceral (gonadal)
adipose depots occurs through high levels of de novo adipocyte differentiation and
progenitor cell proliferation. In contrast, expansion of subcutaneous (inguinal) fat is
mediated primarily by hypertrophy, with little progenitor cell proliferation or
differentiation (Jeffery et al., 2015; Q. A. Wang et al., 2013).
Differences in progenitor cell behavior in response to dietary challenge are likely
mediated by the variations in the depot specific microenvironment (Jeffery et al., 2016).
When subcutaneous adipocyte progenitors are transplanted into visceral depots, they
proliferate and differentiate similarly to the endogenous visceral progenitors in mice fed a
high fat diet. Conversely, when visceral progenitors are transplanted into subcutaneous
adipose tissue, they fail to differentiate or proliferate in response to HFD (Jeffery et al.,
2016). These results indicate that adipocyte progenitor cells are highly plastic and contain
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the ability to proliferate or differentiate in response to the proper signals. This opens the
exciting possibility of manipulating the signaling environment of subcutaneous adipocyte
progenitors to promote de novo differentiation and healthy hyperplastic adipose tissue
expansion in the setting of obesity.

1.6

Adipose Tissue Turnover
Adipose tissue is in a constant state of low level turnover, with mature adipocytes

dying and being replaced by new adipocytes (Rigamonti, Brennand, Lau, & Cowan,
2011; Spalding et al., 2008). Several studies have attempted to estimate the rate of this
turnover in mice and humans, with estimates varying widely. Overall these results range
from a low of about 8.5% per year to a high of 60-100% per year in humans (Neese et al.,
2002; Spalding et al., 2008; Strawford, Antelo, Christiansen, & Hellerstein, 2003). In
mice the estimates suggest a much higher turnover rate of approximately 1.5% to 4.5%
per day (Rigamonti et al., 2011).
The most widely cited study employed
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C measurements of adipocytes, taking

advantage of the spike in atmospheric 14C that occurred due to nuclear tests in the 1960’s
(Spalding et al., 2008). This group found that about 8.5% adipocytes turn over per year in
both lean and obese subjects. They note that obese people have similar rates of turnover
when normalizing to the number of adipocytes, but higher absolute levels of turnover due
to their increased number of adipocytes (Bjorntorp, 1974; Jules Hirsch & Batchelor,
1976; Knittle et al., 1979). Another study developed methods to track the proliferation of
cells and turnover of substrates in slow turnover tissues using 2H2O long term labeling
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(Neese et al., 2002; Strawford et al., 2003). This work suggested much more rapid
turnover, suggesting that 0.16-0.29% adipocytes are replaced per day (58-105%/year).
Interestingly, this study fractionated the tissue and found that the stromal-vascular
compartment, where adipocyte progenitors are located, showed a turnover rate of 4.5% of
cells/day.
In mice, the overall rates of turnover are higher than in humans. One study, using
2

H2O long term labeling found daily rates of 5% turnover in the stromal vascular fraction

and 1-1.5% turnover in the adipocyte fraction (Neese et al., 2002). Follow up studies
using Ki67, BrDU, and dilution of the stable histone H2BGFP, largely support these
conclusions finding ~5% of cells in the stromal vascular fraction are replicating at any
time and that 1-5% of adipocytes are replaced each day (Rigamonti et al., 2011).
Consistent with the human models of obesity, they also find that ob/ob mice show higher
rates of proliferation and adipocyte turnover.
The turnover of adipose tissue requires the coordinated action of multiple cell
types within the tissue. Overall there must be: 1) efficient clearing of dying adipocytes, 2)
a pool of progenitor cells capable of replacing lost adipocytes, 3) a mechanism to keep
the production of new adipocytes and the death of old ones at approximately similar
rates.
Dying adipocytes must be cleared away in an orderly manner to avoid the harmful
effects of releasing free lipid into the tissue (Kai Sun et al., 2011; Y. Lee et al., 2014;
Rosen & Spiegelman, 2014). This clearing away process is dependent upon adipose
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tissue macrophages, which engulf dying adipocytes and are detected within the tissue as
crown-like structures (Hill et al., 2018; Murano et al., 2008; Nelson et al., 2018).
Emerging evidence suggests that macrophages may even recruit adipocyte progenitor
cells to the site of dying adipocytes, through a CD44 – Osteopontin chemotactic axis (Y.
Lee, Kim, Kwon, Maddipati, & Granneman, 2015; Y. Lee, Petkova, & Granneman,
2013). After recruitment, macrophages may then promote adipogenesis by producing
activating ligands for PPARγ, the master regulator of adipogenesis (Y. Lee et al., 2015,
2014). Notably, the endogenous ligand for PPARγ has not yet been identified in-vivo
(Rosen & Spiegelman, 2014). Therefore, these results should be interpreted the caveat
that

the

macrophage

derived

PARγ

ligands

they

report,

9-

and

13-

hydroxyoctadecadienoic acid, may not be playing a role in vivo. Overall, these studies
suggest that clearance of dying adipocytes within the tissue is a regulated process
mediated by tissue resident macrophages. Numerous questions surrounding this process
remain unclear including: 1) why do adipocytes die, 2) what signals control this process,
3) why is turnover necessary, and 4) are there different mechanisms of turnover, some of
which are adaptive and some of which are maladaptive?

1.7

Precursor Origins of Adipocytes
The need for a pool of progenitor cells to maintain adipose tissue can be inferred

from three observations. 1) Adipocytes are post mitotic and therefore cannot replace
themselves (R. Berry, Jeffery, & Rodeheffer, 2013; Hepler, Vishvanath, et al., 2017;
Rosen & Spiegelman, 2014). 2) The number of adipocytes within an individual is
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relatively stable after puberty (i.e. adipocyte number does not decline throughout the
lifetime of the organism) (Jules Hirsch & Batchelor, 1976; Knittle et al., 1979; Spalding
et al., 2008). 3) Adipocytes die and are replaced at a low but appreciable rate (Rigamonti
et al., 2011; Spalding et al., 2008; Q. A. Wang et al., 2013). Therefore, there has been
immense interest in determining the identity, characteristics, and subtypes of adipocyte
progenitor cells. The progress towards answering these questions is summarized here.
As recently as the 1980’s there was considerable speculation about the identity of
the cells responsible for maintaining adipose tissue. Different groups posited that
adipocyte precursors could be derived from cell types as diverse as endothelial cells,
perivascular cells, smooth muscle cells, macrophages, adipose tissue fibroblasts, and
circulating bone marrow progenitors (Hausman, Campion, & Martin, 1980; Hepler,
Vishvanath, et al., 2017). Work in the 1970’s had shown that cells in the stomal-vascular
fraction of rat adipose tissue contained cells capable of differentiating into mature
adipocytes but the identity of these adipogenic cells remained unclear (Bjorntorp et al.,
1978).
Numerous technological and scientific advances by 2008 enabled a wave of more
sophisticated studies probing the identity of adipocyte progenitors. First, the master
regulator of adipocyte differentiation, PPARγ was discovered and a body of research
emerged extensively characterizing the 3T3-L1 model of in vitro adipogenesis (Chawla
& Lazar, 1994; Cristancho & Lazar, 2011; Farmer, 2006; Tontonoz et al., 1994). This
work determined the core features of adipocyte differentiation and defined the gene
expression signatures which characterize adipocytes. Second, technological advances in
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lineage tracing, fluorescence activated cell sorting (FACS), immunofluorescence, and
gene expression analysis (qPCR and RNA-sequencing) enabled more rigorous
classification of the potentially adipogenic subpopulations found in adipose tissue.
In 2008 two foundational studies were published regarding the identity and
anatomic localization of adipocyte progenitor cells. The first employed lineage tracing
with a Pparg reporter mouse in the subcutaneous and retroperitoneal white adipose tissue
of young (p0-p30) mice; they showed that there are Pparg expressing cells located along
the walls of the adipose tissue vasculature (W. Tang et al., 2008). These cells co-express
the mural (vessel wall) cell marker Pdgfrb and do not contain lipid, suggesting they are
indeed potential adipocyte progenitors rather than small mature adipocytes. Lineage
tracing revealed that PdgfrbCre but not the smooth muscle cell specific Sm22Cre traced to
both the Pparg+ mural cells and to adipocytes. They therefore concluded that white fat
progenitors reside in a perivascular location and that they are distinct from smooth
muscle cells (W. Tang et al., 2008).
A second study in 2008 used candidate cell surface markers which were selected
based on their expression in other stem cell compartments, notably the skin and
mammary glands (Rodeheffer, 2008). They found a subset of cells in the stromal vascular
fraction of adipose tissue which were negative for hematopoietic and endothelial cell
markers (CD45 and CD31, hereafter celled Lin-), and positive for the markers CD29,
CD34, Sca-1, and CD24. These Lin-:CD29+:CD34+:Sca1+:CD24+ cells were capable of
producing adipocytes in vitro and in vivo in transplantation studies into lipodystrophic AZip mice (Rodeheffer, 2008).
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These two initial studies were followed by numerous publications, each reporting
their own markers for adipocyte precursors. Thus, there is considerable confusion in the
field as to how these different cellular populations isolated from adipose tissue relate to
one another. The following section will summarize the most common markers employed
in the literature to date. A simplified model of the location and identity of adipocyte
progenitor cells is presented in Figure 1.2. The major markers can be broken into two
categories: cell surface markers and lineage determining markers. Cell surface markers
include: PDGFRα, PDGFRβ, PREF1, and Lin-:CD29+:CD34+:Sca1+:CD24+. Lineage
determining markers include: Pparg, Zfp423, and Wt1.
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Figure 1.2: Preadipocytes reside in the perivascular space.

A multitude of cell types are found within adipose tissue, including fibroblasts,
preadipocytes, adipocytes, immune cells, and vascular (endothelial and smooth muscle)
cells. The prevailing model of adipogenesis suggests that cells committed to the
adipocyte lineage are located within a perivascular niche.
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PDGFRα
Platelet derived growth factor alpha (PDGFRα) was identified in 2010 by two
separate labs as a marker of cells with adipogenic capacity in regenerating muscle (Joe et
al., 2010; Uezumi, Fukada, Yamamoto, Takeda, & Tsuchida, 2010). During glycerol
induced muscle injury, there is a wave of adipogenesis from a cellular subpopulation
called fibro-adipogenic progenitors (FAPs); notably, these cells are distinct from the
muscle stem cells (Joe et al., 2010). In addition to PDGFRα, FAPs express both CD34
and Sca-1, similar to the population of adipocyte progenitors identified by Rodeheffer et
al in 2008 (Rodeheffer, 2008).
Based on these similarities, Lee et al examined whether PDGFRα is a marker of
adipocyte progenitor cells in visceral and subcutaneous white adipose depots (Y. Lee,
Petkova, Mottillo, & Granneman, 2012). They employed two models of adipogenesis:
β3-agonist stimulation to induce the formation of beige fat and high fat diet (HFD) to
induce the formation of white fat. Brdu and Edu labeling studies of the visceral
(epididymal) white adipose tissue revealed that in both models of adipogenesis, the
proliferating cells were indeed PDGFRα+:CD34+:Sca1+ when examined by flow
cytometry and immunofluorescence. PDGFRα+ cells are fibroblast like with multiple
elongated processes touching components of the ECM and vasculature; although many
are proximal to the vasculature, they are not explicitly perivascular, in contrast to the
location of PDGFRβ cells (Y. H. Lee, Petkova, Mottillo, & Granneman, 2012; W. Tang
et al., 2008). Lineage tracing with PdgfraCreER confirmed the contribution of these cells to
white and beige fat under conditions of high fat diet and β3-adrenergic stimulation
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respectively (Y. H. Lee et al., 2012). A separate group employed a PdgfraCre lineage
reporter and showed tracing of PDGFRα+ cells to adipocytes during development and
under normal unstimulated conditions (R. Berry & Rodeheffer, 2013).
Multiple subsets of PDGFRα+ adipocyte progenitors have since been reported.
CD44+/PDGFRα+ cells are recruited by macrophages to the sites dying adipocytes in the
visceral white adipose tissue under conditions of HFD, β3 adrenergic stimulation, and
physical injury (Y. Lee et al., 2015, 2013). These cells are highly proliferative and are
presumed to be differentiating preadipocytes, primed to replace the dying fat cells.
CD9High/PDGFRα+ cells are enriched in the visceral adipose tissue in mouse models of
obesity. Compared to CD9Low/PDGFRα+ cells, CD9High/PDGFRα+ progenitors are less
adipogenic and exhibit a pro-fibrotic myofibroblast phenotype (Marcelin et al., 2017).
Indeed these cells may be responsible for the maladaptive remodeling of the adipose
tissue ECM observed in obesity (Divoux et al., 2010b; Sun, Tordjman, Clément, &
Scherer, 2013). Our lab has reported that a subset of PDGFRα+ cells with high
expression of EBF2 are primed to become thermogenic beige adipocytes, while those
with low expression are primed to become white adipocytes (W. Wang et al., 2014). This
distinction is somewhat unsurprising as EBF2 is a transcription factor responsible for
determining and maintaining the thermogenic program in adipocytes (Rajakumari et al.,
2013; Shapira et al., 2017; Stine et al., 2016).
Overall PDGFRα has rapidly become an accepted general marker for adipocyte
progenitor cells. It is clear however that considerable heterogeneity exists within this
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larger population. Therefore, future work will be needed to determine how the various
already identified and yet unidentified subsets relate to each other.
PDGFRβ
Platelet derived growth factor beta (PDGFRβ) was among the first markers used
in the identification of adipocyte progenitors (W. Tang et al., 2008). PDGFRβ cells are
typically described vascular “mural cells” which reside along the outer walls of blood
vessels (Hong et al., 2015; Vishvanath et al., 2016). Lineage tracing experiments have
shown that cells marked by expression of Pdgfrb (PdgfrbrtTA-Tre-Cre, Rosa26mT/mG)
generate new white adipocytes in the epididymal adipose tissue depot on high fat diet.
Indeed in one study, after 8 weeks of HFD, 10% of adipocytes within the tissue were
derived from newly differentiated Pdgfrb+ progenitors (Vishvanath et al., 2016). De novo
adipocyte differentiation from these cells is important for protection from metabolic
disease. Genetic deletion of Pparg in Pdgfrb+ progenitors leads reduced adipogenesis on
HFD and worsened insulin sensitivity; overexpression of Pparg has the opposite effect
(Shao, Vishvanath, et al., 2018).
Furthermore, Pdgfrb+ progenitors (PdgfrbrtTA-Tre-Cre, Rosa26mT/mG) can generate
beige adipocytes after prolonged (2 weeks) but not short bouts of cold exposure in the
inguinal adipose tissue (Vishvanath et al., 2016). This is in contrast to Pdgfra+
progenitors (PdgfraCreER Rosa26mT/mG), which generate new beige adipocytes within days
(Y. H. Lee et al., 2012; Q. A. Wang et al., 2013). Interestingly, several groups report the
existence of cells which co-express PDGFRα and PDGFRβ in the gonadal and inguinal
fat of mice (Hong et al., 2015; Shao, Vishvanath, et al., 2018; Vishvanath et al., 2016).
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However, another report however fails to find any PDGFRα+ cells which are also
positive for PDGFRβ in these depots (Y. H. Lee et al., 2012). Therefore, the overlap
between the function and identity of PDGFRα+ and PDGFRβ+ cells remains an open
question for the field.
Lin-:CD29+:CD34+:Sca1+:CD24+
Variations on the “Lin-:CD29+:CD34+:SCA1+:CD24+” FACS sorting strategy to
isolate adipocyte progenitors have been widely reported in the literature(R. Berry et al.,
2013; Hong et al., 2015). The most common change is to omit CD24 and/or CD29 from
the isolation strategy. For example, Lin-:CD34+ cells in human adipose tissue have been
described as adipogenic and residing in a perivascular location (Traktuev et al., 2008;
Zimmerlin et al., 2010). Another group has shown that Lin-:Sca1+:CD34+ cells derived
from mouse adipose tissue are capable of adipogenesis upon transplantation (Joe, Lin,
Even, Vogl, & Rossi, 2009).
Nearly all Lin-:CD29+:CD34+:Sca1+ cells are also PDGFRα+ (R. Berry &
Rodeheffer, 2013). The addition of CD24 to this sorting strategy enables separation of
these cells into two pools with different biological activities. Compared CD24+ cells,
CD24- cells are less proliferative and show higher expression of adipocyte identity genes
such as Pparg, Lpl, AdipoQ, and Fabp4 (R. Berry & Rodeheffer, 2013). Transplantation
studies and more descriptive analyses indicate that CD24+ cells directly produce CD24cells during the course of adipogenesis in both visceral and subcutaneous depots (R.
Berry & Rodeheffer, 2013; Jeffery et al., 2015, 2016).
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PREF1
Preadipocyte factor 1 (Pref1), also known as Dlk1, is an epidermal growth factor
(EGF) like protein that inhibits adipocyte differentiation in a paracrine manner (Hudak &
Sul, 2013). PREF1 is a transmembrane protein whose expression decreases throughout
the course of differentiation in the 3T3-L1 model of in vitro adipogenesis (Smas, Chen, &
Sul, 1997; Smas & Sul, 1993). It is cleaved by TNFα converting enzyme to release a
soluble form into the extracellular space. The soluble active form suppresses
adipogenesis via upregulation of SOX9 which suppresses transcription of C/EBPs, a
family of transcription factors which are critical for adipogenesis (Hudak & Sul, 2013).
Pref1 has the components of an ideal marker for adipocyte progenitor cells as it
inhibits adipogenesis and is lost during differentiation. It has primarily been described as
a marker of very early adipocyte progenitors during embryonic development (Hudak et
al., 2014a). Lineage tracing using a Pref1 reporter mouse indicates that Pref1+ cells
appear as early as E10.5 during mouse development and go on to develop into adipocytes
in the inguinal fat. Pref1+ are also detected in the visceral adipose tissue which develops
later. Finally, ablation of Pref1+ cells using diphtheria toxin leads to lipodystrophy,
indicating that these cells are part of the adipocyte cellular lineage.
PPARγ
PPARγ is required for adipogenesis therefore early studies attempted to identify
adipocyte progenitor cells based on their expression of this key transcription factor (W.
Tang et al., 2008). Cells expressing Pparg are found along the adipose tissue vasculature
and co-express PDGFRβ (W. Tang et al., 2008). The fact that Pparg is a transcription
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factor (and therefore intracellular) and highly expressed in adipocytes have limited its
utility as a lineage tracing reporter.
Nevertheless, one interesting study used a Pparg lineage tracing reporter
(PpargtTA-Tre-Cre R26RLacZ) during early development to demonstrate that distinct
progenitor cells are responsible for adipose tissue development versus maintenance
(Jiang, Berry, Tang, & Graff, 2014). Using this doxycycline suppressible system, Pparg+
(LacZ+) cells are detectable in the inguinal WAT as early as E10.5. However,
suppression of the reporter at this early stage leads to an unlabeled fat pad at birth.
Deletion of Pparg in Pparg+ cells (PpargtTA-Tre-Cre/fl ) at E10.5 leads to normal adipose
tissue at birth, but a progressive lipodystrophy with ageing. Combined these results
indicate that two separate pools of progenitors regulate the initial development of adipose
tissue (organogenesis) and maintenance of adipose tissue in adulthood (Jiang et al.,
2014).
ZFP423
Zinc finger protein (ZFP) 423 is a transcription factor that is enriched in
fibroblasts from adipose tissue compared to fibroblasts from non adipogenic tissues
(Gupta et al., 2010). It has been reported as a marker of “committed preadipocytes” based
on one study employing a Zfp423-GFP reporter mouse. Subsequent work has indicated
that there is substantial overlap between Zfp423-GFP+ cells and PDGFRβ+ cells (Gupta
et al., 2012; Vishvanath et al., 2016).
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WT1
Wilms Tumor 1 (WT1) is a transcription factor with key roles in the development
of the heart and kidneys (Chau et al., 2014). Gene expression and lineage tracing reporter
lines (Wt1GFP and Wt1Cre Rosa26mT/mG) indicate that Wt1 is a selective marker of visceral
but not subcutaneous adipocyte progenitor cells (Chau et al., 2014; Hepler, Shao, et al.,
2017).
Other Markers
Various other markers have been reported to define different subsets of
adipogenic progenitor cells each with different activities. Several groups have shown
lineage tracing to adipocytes with smooth muscle markers such as smooth muscle actin
(SMA) under normal conditions and myosin heavy chain 11 (Myh11) under conditions of
prolonged cold exposure (D. C. Berry, Jiang, & Graff, 2016; W. Tang et al., 2011). As a
final example, CD38 is reported to mark committed preadipocytes (similar to the
distinction between CD24+ and CD24- cells discussed above) (Carrière et al., 2017).
Other Origins
Some studies have suggested alternative origins for adipocytes such as from bone
marrow progenitors or endothelial cells (Jr, Majka, Grazia, Gill, & Klemm, 2006; Majka
et al., 2010; Tran et al., 2012). More carefully controlled work has determined that
adipocytes do not derive from these lineages under normal conditions (R. Berry &
Rodeheffer, 2013). The notable exception is that studies of human bone marrow
transplant recipients have shown that approximately 10% of their subcutaneous
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adipocytes are derived from donor rather than host cells (Gavin et al., 2016; Rydén et al.,
2015).
Beige Adipocytes
Beige adipocytes have been variously reported to arise from the de novo
differentiation of progenitor cells or transdifferentiation/phenotype conversion of mature
white adipocytes (Rosenwald, Perdikari, Rülicke, & Wolfrum, 2013; Q. A. Wang et al.,
2013). Proposed markers for beige adipocyte progenitors include many of the same ones
discussed for white fat progenitors: PDGFRα (Y. H. Lee et al., 2012; W. Wang et al.,
2019, 2014), PDGFRβ (Vishvanath et al., 2016), SMA+ (D. C. Berry et al., 2016),
MYH11+ (D. C. Berry et al., 2016; J. Z. Long et al., 2014). There is considerable
disagreement in the field as different groups have reported widely varying levels of
contribution from each of these progenitor cell types to the beige adipocyte population.
One potential explanation for this disagreement may be that the mechanism by
which an organism produces beige adipocytes is path dependent. After a bout of cold
exposure followed by a return to warm temperatures, beige adipocytes slowly convert to
a white adipocyte phenotype (Roh et al., 2018; Rosenwald et al., 2013). They lose Ucp1
expression, mitochondrial density, and remodel their lipid droplets from a multilocular to
a unilocular architecture over the course of approximately 4 weeks (Roh et al., 2018).
After this rewarming induced phenotype conversion, the gene expression patterns of
previously beige adipocytes are nearly indistinguishable from bona fide white adipocytes
(never beige). However, these cells are able to rapidly reactivate the thermogenic
program upon a second episode of cold exposure (Rosenwald et al., 2013). Increased
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levels of the histone mark H3K4me1, commonly associated with active or primed
enhancers, in previously beige adipocytes is reported to mediate the epigenetic memory
of cold exposure (Local et al., 2018; Roh et al., 2018). Consistent with this, previously
beige adipocytes have higher levels of H3K4me1 at the sites of thermogenic genes like
Ucp1 and Cpt1b (the mitochondrial fatty acid transporter and rate limiting step in fatty
acid oxidation) (Roh et al., 2018).
The balance of de-novo differentiation versus reactivation of previously beige
adipocytes is likely dependent how many previously beige adipocytes are within the
tissue. In a mouse with an extensive history of cold exposure, reactivation will likely
predominate; in a cold naïve mouse, most beige adipocytes are expected to derive from
de novo adipogenesis. Notably, room temperature, which can vary widely between mouse
housing facilities, is cold enough to induce thermogenesis in mice (Fischer, Cannon, &
Nedergaard, 2018). This suggests that mice housed at thermoneutrality versus at room
temperature before cold exposure may recruit different pools of progenitors for beige
adipogenesis. Likewise, the age of mice and length of cold exposure likely modulate
which progenitor populations respond to cold stimulus (D. C. Berry et al., 2017;
Vishvanath et al., 2016; W. Wang et al., 2019). Overall, more carefully controlled studies
in which the complete cold exposure history of the mouse is known, are needed to better
understand the precursor origins of beige adipocytes.
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1.8

Outlook
The previous sections have outlined the central role of adipose tissue in the

context of normal physiology and highlighted its capacity to either protect from or
contribute to obesity associated metabolic decline. While much is already known, key
questions about the fundamental biology of adipose tissue remain. Currently, there is a
major effort in the field to advance two strategies for the treatment of metabolic disease:
1) Promoting hyperplastic subcutaneous adipose tissue expansion in the setting of obesity
and 2) Increasing beige adipogenesis to augment energy expenditure. However, the
ability to develop these strategies is hampered by a lack of agreement about the identity
and subtypes of adipocyte progenitors within adipose tissue. My thesis work aimed to
establish consensus in the field by answering the following questions:
First, what are the biologically meaningful subdivisions of adipocyte progenitor
cells and where are these cells located in vivo? Previous studies have used candidate cell
surface marker genes and lineage tracing approaches to classify cells isolated from the
stromal vascular fraction of adipose tissue. While informative, these approaches were not
comprehensive and may not have captured the most biologically meaningful subdivisions
of progenitor cells (Figure 1.3). Therefore, we employed newly available single cell RNA
sequencing (scRNA-Seq) technology to comprehensively profile the stromal vascular
cells from mouse and human adipose tissue in an unbiased manner. These analyses were
followed by computational lineage prediction methods, cell sorting, in vitro assays, and
transplantation studies to define the location of and relationships between newly
identified subtypes of adipocyte progenitor cells.
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Second, how do these progenitor cell populations change in response to common
adipogenic stimuli such as diet induced obesity? We use flow cytometry and in vitro
assays to provide evidence that progenitor cell exhaustion, specifically in the visceral
adipose tissue, may be a feature of obesity.
Third, are there distinct markers for cells committed to the white rather than the
beige adipogenic lineage? Previous studies have been limited by a lack of precise control
over the thermal history of their mouse models. This work employed a novel model of
cold naïve mice to examine the progenitor cell responses to cold exposure but failed to
find evidence for the existence of a specialized beige preadipocyte.
Overall, the work presented herein defines the lineage hierarchy of adipocyte
progenitor cells, describes a novel anatomic niche for their location, and provides clarity
for the field about the identity of adipocyte progenitors moving forward.
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Figure 1.3: Expected cellular composition of subcutaneous white adipose tissue.
The stromal vascular fraction of subcutaneous white adipose adipose tissue is expected to contain
numerous mesenchymal populations which can be identified based on their expression of one or
more common mesenchymal markers. Early progenitor cells are expected to express genes
associated with niche maintenance. Committed preadipocytes are expected to express genes
associated with adipocyte identity.
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Chapter 2: Identification of a Mesenchymal Progenitor Cell Hierarchy
in Adipose Tissue
This chapter is adapted from: Merrick, David., Sakers, Alexander., Irgebay, Zhazira.,
Okada, Chihiro., Calvert, Catherine., Morley, Michael P., Percec, Ivona., Seale, Patrick.
Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science (80-.
). 364, eaav2501 (2019). (Merrick et al., 2019)
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2.1

Abstract
Metabolic health depends on the capacity of adipose tissue progenitor cells to

undergo de novo adipogenesis. However, the cellular hierarchy and mechanisms
governing adipocyte progenitor differentiation are incompletely understood. Here, we
identify a lineage hierarchy consisting of distinct mesenchymal cell types present in
mouse adipose tissue. Cells marked by DPP4 expression are highly proliferative,
multipotent progenitors that, during murine subcutaneous adipose development, give rise
to ICAM1+ committed pre-adipocytes and a related adipogenic cell population marked
by Clec11a and F3/CD142 expression. Transforming growth factor-β maintains DPP4+
cell identity and inhibits adipogenic commitment of DPP4+ and CD142+ cells.
Intriguingly, DPP4+ progenitors reside in the reticular interstitium, a recently discovered
fluid-filled space within and between tissues, including adipose depots. Taken together,
this study defines the adipose lineage hierarchy and identifies a new anatomical niche for
multipotent mesenchymal progenitors.
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2.2

Introduction
White adipose tissue (WAT) stores excess nutritional energy in the form of

triglycerides, which can be released for use in other tissues during periods of energy
demand, such as during fasting and physical activity. The capacity for adipocytes to store
chemical energy in lipid droplets protects other organs against the toxic effects of ectopic
lipid deposition. Adipose tissue expands by increases in fat cell size (hypertrophy) and/or
number (hyperplasia). Hyperplastic growth, mediated by the differentiation of progenitor
cells (i.e. adipogenesis), is critical for proper adipose tissue function (Carobbio,
Pellegrinelli, & Vidal-Puig, 2017; Gustafson et al., 2013; Sun et al., 2013). Defects in this
process cause adipose fibrosis and inflammation, contributing to systemic insulin
resistance (Gyllenhammer, Alderete, Toledo-Corral, Weigensberg, & Goran, 2016).
Conversely, enhancing adipogenesis prevents maladaptive adipocyte hypertrophy,
reduces ectopic lipid accumulation and ameliorates metabolic disease (Khan et al., 2009;
Pasarica et al., 2009; Senol-Cosar et al., 2016; Shao, Vishvanath, et al., 2018; W. Tang et
al., 2011).
Adipose progenitor cells have been isolated based on their expression of common
progenitor/mesenchymal cell surface markers, including PDGFRα, PDGFRβ, CD29,
CD34, SCA1/LY-6A and CD24 (Hepler, Vishvanath, et al., 2017; Y. Lee et al., 2012;
Rodeheffer, 2008). PREF1 (DLK1) and the adipose lineage marker PPARγ are reported
to mark adipogenic cells that are closely associated with blood vessels in adipose tissue
(Hudak et al., 2014a). Finally, mural and smooth muscle-related cells that express Acta2
(smooth muscle actin), Myh11 or Pdgfrβ contribute to adipocyte formation under certain
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conditions (D. C. Berry et al., 2016; Vishvanath et al., 2016). However, the overlap,
heterogeneity and developmental inter-relationships between these and other described
populations are incompletely understood.

45

2.3

Results

Profiling and lineage trajectory analysis of adipocyte progenitor cells
We applied single cell RNA sequencing to identify and profile progenitor cells in
an unbiased manner from the developing subcutaneous inguinal WAT (iWAT) of 12-dayold mice (p12). At this stage, adipocytes are rapidly developing from progenitor cells,
allowing us to capture the continuum of cell states spanning differentiation. We
hypothesized that we would observe numerous cell types, from less developed more
“stem-like” cells, through committed preadipocytes, to even some small adipocytes
(Figure 1.3).
Mature lipid-laden adipocytes, which in mice range from 20-150 µM in diameter,
are fragile and highly buoyant (Hagberg et al., 2018; Majka et al., 2014). Since these
were likely to be incompatible with the microfluidics channels of the 10x genomics
chromium device used for scRNA sequencing, they were depleted from the stromal
vascular cells (SVCs) by low-speed centrifugation. This technique separates the digested
adipose tissue into two fractions: the floating layer containing mature adipocytes and the
pelleted stromal vascular layer containing all other cell types in the tissue. SVCs were
then depleted of dead cells (DAPI+) and of CD45+ leukocytes using fluorescence
activated cell sorting (FACS) and analyzed via single cell RNA sequencing (Figure
2.1.A). Unsupervised clustering analysis of the gene expression profiles using Seurat 3.0
identified 10 distinct cell types (Figure 2.1.B-C).
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Figure 2.1: Single cell RNA seq reveals the heterogeneity of subcutaneous adipocyte
progenitors.
(A) FACS gating strategy for isolation of stromal-vascular cells used in single-cell RNASeq
analysis Debris, most leukocytes and doublets were excluded based on forward and side scatter
profiles. Live cells were selected by the absence of DAPI staining. CD45(-) cells were sorted to
exclude leukocytes from the downstream analysis. Control cells (unstained with antibody) were
included to define the gating strategy. (B) Unsupervised clustering of 11,423 cells (mean number
of genes per cell = 1977) from the subcutaneous WAT of p12 pooled male and female C57BL/6J
mouse pups reveals 10 distinct cell groups represented on a tSNE map (relevant marker genes are
listed in parentheses). (C) Individual gene tSNE and violin plots showing the expression levels
and distribution of representative marker genes. The y axis is the log-scale normalized read count.
Adapted with permission from (Merrick & Sakers, 2019).
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We wanted to focus our analysis on cells which may be part of the adipocyte
lineage and therefore explored the data to identify clusters of cells expressing genes that
were previously reported to mark adipocyte progenitors (Figure 1.3). Canonical
mesenchymal progenitor markers Cd34, Pdgfra, Pdgfrb, Ly6a (Sca1) and Thy1 (Cd90),
were predominantly expressed in groups #1-3 (Figures 2.2 and 2.3). Since adipocyte
progenitors have been previously identified as containing one or more of these marks, we
next examined the distinctions between these three clusters of cells, hypothesizing that at
least one of these subgroups would represent preadipocytes, i.e. cells committed to the
adipocyte lineage.
Group 1 cells (blue), which we named “interstitial progenitors”, were
characterized by the expression of Dipeptidyl peptidase 4 (Dpp4), Wnt2, Bmp7 and Pi16
and by the lack of expression of adipocyte marker genes (Figures 2.1.C, 2.2, and 2.3).
Group 2 cells expressed Intercellular adhesion molecule 1 (Icam1) and Dlk1 (Pref1)
along with several adipocyte-identity genes, including Pparg, Fabp4 and Cd36,
suggesting that these cells could be “committed preadipocytes” (Figures 2.1.B, 2.2 and
2.3). Group 3 cells expressed Clec11a, Fmo2, as well as Tissue factor (F3/CD142),
which is a marker of “adipogenesis-regulatory cells” (Aregs) that were recently reported
to be non-adipogenic themselves and capable of inhibiting adipogenesis in a paracrine
manner (Schwalie et al., 2018). Combined these three clusters contained the majority of
the cells profiled.
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Figure 2.2: Marker gene expression patterns for the various cell groups identified in
developing (p12) subcutaneous adipose tissue.
Single cell tSNE plots from the stromal-vascular fraction of 12 day old pooled male and female
C57/BL6J mouse pups, highlighting the expression patterns of selected genes from the literature
(mesenchymal stem cell markers, gray box), and cluster-specific marker genes.
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Figure 2.3: Marker gene expression profiles for the various cell groups identified in
developing (p12) subcutaneous adipose tissue.
Single cell violin plots, showing the mean and variance in expression density across all the singlecell groups identified in the stromal-vascular fraction of iWAT from 12 day old pooled male and
female C57/BL6J mouse pups. Selected marker genes for each group and from the literature are
highlighted.
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We next examined the smaller clusters of cells and attempted to assign them
identities based on their gene expression profiles. The two major components of the
vasculature, smooth muscle cells (group 8) and endothelial cells (group 9) were identified
based on the expression of alpha-smooth muscle actin (Acta2) and platelet endothelial
adhesion molecule-1 (Pecam1) respectively (Figures 2.1.B, 2.2, and 2.3) (Woodfin,
Voisin, & Nourshargh, 2007). Group 10 showed expression of myelinating proteins
including, myelin protein zero (Mpz), myelin basic protein (Mbp), and proteolipid protein
1 (Plp1). These were therefore identified as Schwann cells which are responsible for
myelinating peripheral neurons (Monk, Feltri, & Taveggia, 2015). Adrenergic signaling
from neurons plays a key role in coordinating the response of adipose tissue to
environmental conditions (such as fasting and cold exposure) strengthening our
confidence in identifying group 10 cells as Schwann cells (Grujic et al., 1997; Lafontan
& Berlan, 1993). Clusters 5 and 6 represent less abundant cell populations whose gene
expression patterns did not readily reveal their role in the tissue.
Group 4 was specifically marked by Wnt6 and Sfrp5 expression but did not show
detectable levels of mesenchymal marker genes such as Pdgfra or Thy1. Group 4 appears
highly related to group 3 cells based on some overlap in their gene expression patterns
(notably Vit and Ifitm1). Interestingly, Wnt6 is known to inhibit adipogenesis and
promote osteogenesis, while Sfrp5 is a member of the secreted frizzled-related protein
family, which sequesters WNTs to reduce their signaling (Cawthorn et al., 2012; Heller et
al., 2002). The expression of both inhibitors of adipogenesis and inhibitors of inhibitors
of adipogenesis suggest that these cells may be working to maintain a specialized niche
54

within the tissue; this raises the possibility that these cells may represent a pool of stemlike cells within the tissue.
Group 7 (yellow) was classified as “adipocytes” based on their high expression
levels of mature adipocyte-specific genes (e.g. Adipoq, Plin1, Car3) and lack of
expression of mesenchymal progenitor markers (ex. Pdgfra). These cells likely represent
newly formed adipocytes without significant lipid stores, making them denser than water,
which co-purified with the pelleted stromal cell fraction rather than with the floating
adipocyte fraction. Notably, these cells do not form an isolated cluster but rather lie
immediately next to the Group 2 cells suggesting the presence of a relationship between
these two cell types.
The SVC compartment of adult adipose tissue from mice housed at
thermoneutrality (30°C) for their entire lives displays similar cellular diversity, including
prominent populations of mesenchymal cell groups 1-3 (Figure 2.4.A-C). As anticipated
populations of smooth muscle cells (group 4), endothelial cells (group 5), and Schwann
cells (group 10) were all identified based on the markers discussed previously (Figure
2.4.A). Notably, immune cells were included in this experiment and populations of Tcells (Cd45+, Cd3d+), B cells (Cd45+, Cd19+), macrophages (Cd45+, Cd68+), and
dendritic cells (Cd45+, Ccl5+), were all identified based on the expression of commonly
accepted marker genes (Wetzels et al., 2018). In contrast to the data from the p12 pups,
where Groups 1-3 were present in roughly equal proportions, in the thermoneutral housed
adults, Group 1 (Dpp4+) and Group 2 (Icam1+) cells appear to be the major
mesenchymal populations with Group 3 (Cd142+/Clec11a+) cells less abundant in the
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tissue. Overall however, the populations, cluster defining genes, and composition of the
SVF appear remarkably similar in the adult and pup datasets.
From these data, we formed the hypothesis that Group 2 cells (Icam1+) are
committed preadipocytes due to their close proximity to adipocytes on the tSNE and
expression of both adipocyte identity genes and mesenchymal marks. Additionally, we
hypothesized that Group 1 (Dpp4+) cells may represent a less committed progenitor cell,
capable of giving rise to the other cell types in the tissue, based on the expression of
numerous growth factors implicated in niche maintenance (BMPs and WNTs) and the
presence of mesenchymal marks (Figure 1.3). We sought to examine this hypothesis
using computational lineage prediction techniques which employ a concept called
“psuedotime”. These techniques take advantage of the large number of cells in single cell
data sets and the asynchronous nature of many developmental hierarchies to identify cells
in (nearly) all states along the continuum from precursor to product (Trapnell et al.,
2014).
We examined potential precursor-product relationships between the identified
mesenchymal populations using Monocle 2 to perform in silico cell trajectory analyses on
the data from the p12 pups (Qiu et al., 2017). Pseudotemporal analysis predicted that
Group 1 interstitial progenitors have two developmental trajectories: (Cell Fate A) Group
2 “preadipocytes”, terminating in Group 7 “adipocytes”; and (Cell Fate B) Group 3 and 4
cells (Figure 2.5.A). Group 3 cells appear to represent an intermediary cell type between
group 1 interstitial progenitors and Group 4 cells.
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A split heatmap shows select genes which Monocle 2 identified as defining the
origin (center genes), endpoints (far right and far left genes), and intermediate states
which define the course of the cell trajectories (Figure 2.5.B). As expected, this includes
many of the cluster defining genes identified for each of the cell types. Cells transiting
from Group 1 stromal progenitors into preadipocytes are marked by the stage-selective
expression of several genes, including Nrep, Prss12, Ccl7, Gpx3, Ctsh, Ctsb and Cyb1b1
(Figure 2.5.B). Altogether, these analyses suggest that Group 1 progenitors (Dpp4+)
provide a source of both Group 2 committed preadipocytes and Group 3 Cd142+ cells.
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Figure 2.4: Single cell RNA seq reveals similar populations of subcutaneous adipocyte
progenitors in adults as in pups.
(A) Unsupervised clustering of 9,652 stromal-vascular cells harvested from the subcutaneous
iWAT of adult male 129S6/SvEv mice housed at thermoneutrality (mean genes per cell = 1,702).
The tSNE map depicts 10 distinct cell clusters (relevant marker genes in parenthesis). (B)
Expression of selected genes from the literature (mesenchymal stem cell markers, gray box), and
cluster-specific marker genes. (C) Violin plots showing the mean and variance in expression
density of selected genes across all the groups.

59

60

Figure 2.5: Monocle cell trajectory analysis predicts lineage hierarchy in adipocyte
progenitors.
(A) Pseudotemporal cell ordering of groups 1 to 4 and adipocytes along differentiation
trajectories by using Monocle. Pseudotime (arbitrary units) is depicted from dark to light blue
(left). Group identities were overlaid on the pseudotime trajectory map (right). (B) The origin of
Pseudotime is represented in the center of the heatmap. Genes differentially expressed along ‘Cell
Fate A’ and ‘Cell Fate B’ trajectory are depicted towards the left and right respectively.
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Development of a FACS strategy to isolate group 1- 3 cells from mouse subcutaneous
WAT
To investigate the function of these cell populations, we developed fluorescence
activated cell sorting (FACS) strategies for isolation of Group 1-3 cells from murine
subcutaneous adipose tissue. To develop this strategy, we examined the single cell data
for marker genes that fit the following criteria: 1) Expressed at the cell surface, 2) Highly
expressed, 3) Selective (i.e. highly enriched in only one group), 4) Generalizable (i.e.
compatible with cells from both p12 pups and adult mice). Furthermore, we wanted to
have at least one positive mark for each cellular population rather than relying solely on
negative selection to achieve specificity. Since there are well validated FACS strategies
for depleting immune (CD45+), endothelial (CD31+), and red blood cells (RBC lysis
and/or Ter119+) cells, we planned to gate these cells away at the beginning of each
isolation. Therefore, we accepted marker genes that fit our criteria when looking at
Groups 1-3 but were also expressed on immune, endothelial, or red blood cells.
Based on these criteria we identified Dpp4 as a selective marker of Group 1 cells,
Icam1 as a selective marker of Group 2 cells (note: Pref1 is a more selective marker, but
is only present in pups), and Cd142 as a selective marker of Group 3 cells. We therefore
developed the FACS strategy in Figure 2.6. First cells are sorted on the basis of size and
complexity and singlets are isolated using the standard technique of plotting FSC-H vs
FSC-W. Second, live cells are isolated on the basis of negative DAPI staining and nonimmune/non-endothelial cells are isolated on the basis of negative staining for CD45 and
CD31 respectively. Fluorophores were chosen such that membrane Tomato labeled cells
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could be isolated in the next step, allowing for the isolation and tracking of cells in coculture and transplantation experiments. In the final steps, Groups 1-3 were isolated using
the following marks: Group 1 (DPP4+, CD142 (-)) cells (hereafter DPP4+), Group 2
(ICAM1+; CD142(-)) (hereafter ICAM1+), and Group 3 (CD142+).
To validate this purification strategy, we FACS sorted DPP4+, ICAM1+, and
CD142+ cells and performed bulk RNA Sequencing in triplicate on the isolated cellular
populations from p12 pups (Figure 2.7.A). Differential expression was determined using
DESeq2 and group defining genes were defined for each of the DPP4+, ICAM1+, and
CD142+ populations. A group defining gene was identified as one that is upregulated in
each of the possible pairwise comparisons (ex. Significantly upregulated in both DPP4+
vs ICAM1+ and in DPP4+ vs CD142+). These gene lists were then used to interrogate
the single cell data from Groups 1-3 to generate the heatmaps presented in Figure 2.7.B.
These data show strong correlation in the transcriptomes between Group 1 and DPP4+
cells, Group 2 and ICAM1+ cells, and Group 3 and CD142+ cells, supporting the validity
of this isolation strategy (Figure 2.7.B).
Finally, we compared the abundance of each of these cellular populations —
DPP4+, ICAM1+, and CD142+ — in SVC preparations from both p12 and adult mice
(Figure 2.8.A-B). All three populations were readily identified in both pup and adult mice
and in roughly similar proportions (Figure 2.8.A-B). Indeed, there were no significant
differences between the proportion of ICAM1+ and CD142+ cells in adults and pups.
There were significantly more DPP4+ cells in the adult IWAT than in the pup IWAT
(~30% in adults vs ~20% in pups of live lin(-) cells) (Figure 2.8.C). Overall, the data
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presented in Figures 2.6-2.8 indicate that the FACS sorting strategy we developed is valid
for isolating Group 1-3 cells from pup and adult mouse subcutaneous WAT.
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Figure 2.6: FACS strategy for isolation of cell groups from mice for functional studies.
FACS gating strategy for isolation of DPP4+, ICAM1+ and CD142+ cells from mouse adipose
tissue. Debris and most leukocytes were removed by size and doublets were excluded. Live cells
were selected by the absence of DAPI staining and Lin(-) cells were selected by the absence of
staining for CD45 and CD31 (APC-Cy7). Unstained control cells were included to define the
gating strategy (left). CD142+ cells were selected first (CF647), then the remaining CD142(-)
cells were further gated against DPP4 (FITC) and ICAM1 (PE/Cy7) (right)
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Figure 2.7: Validation of FACS strategy by bulk RNA sequencing.
(A) FACS gating strategy that was used to enrich DPP4+, ICAM1+ and CD142+ cells for bulk
RNA-Seq analysis. Briefly, CD31(-) and CD45(-) cells were stained for DPP4, ICAM1 and
CD142. Groups were purified as follows: Group 1 (CD142-, DPP4+), Group 2 (CD142-,
ICAM1+) and Group 3 (CD142+). DP = double positive (DPP4+, ICAM1+, CD142-); DN =
double negative (DPP4-, ICAM1-, CD142-). (B) Heatmap of the most significant differentially
expressed genes in freshly isolated DPP4+ (blue), ICAM1+ (red) or CD142+ (green) cells from
12 day old pooled male and female C57/BL-6J mouse pups analyzed by bulk RNA-Seq (right).
Heatmap of 12 day old pooled male and female C57/BL-6J mouse pups single-cell RNA-Seq
(Group 1-3 from Fig 1A) (left).
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Figure 2.8: DPP4+, ICAM1+ and CD142+ populations are found at comparable abundance
in p12 pups and adult iWAT.
(A) FACS plots from representative iWAT SVF from 12 day old pooled male and female
C57/BL-6J mouse pups (left) and 8-10 week old adult male CD1 or C57/BL-6J mice (right). (B)
Quantification of relative population abundance from (A) (n = 9 BR). (C) Quantification of
relative population abundance (n = 9 BR/group)
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DPP4+ cells are multipotent mesenchymal progenitors
We sought to determine the functional properties of these cells in vitro in order to
better understand their role in vivo. We therefore performed a series of assays to
determine the adipogenic, proliferative, and alternative-lineage (ex. osteogenic)
differentiation potentials of each cell type. These were performed with the hypothesis that
the DPP4+ cells would be the most “stem like” and should have the most alternate
lineage potential and proliferative activity, while the ICAM1+ cells are the most
committed to the adipocyte lineage and therefore should show the highest adipogenic
potential.
We first examined the morphology of these cells in culture. Cultured DPP4+ cells
displayed a conspicuous rounded/flattened morphology, whereas ICAM1+ and CD142+
cells had a fibroblastic morphology with elongated protruding lamellipodia (Figure
2.9.A). We next performed a series of differentiation assays with different amounts of
adipogenic induction in order to precisely determine which of the cell types were the
most and least adipogenic. For these assays, cells were plated at high confluency and
treatments were initiated within 48 hours of plating. These conditions were chosen to
minimize the amount of time cells spent in culture and to attempt to better preserve the in
vivo properties of these cells.
In cultures of cells derived from young mice (p12-30), ICAM1+ cells showed
rare instances of spontaneous adipogenesis in control media (DMEM/F12 + 10% FBS)
without the addition of any inducers, implying that these cells are highly committed to
the adipocyte lineage (Figure 2.9.B). Spontaneous adipogenesis was never observed in
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DPP4+ or CD142+ cells. Quantification of adipogenesis using an automated image
analysis algorithm performed on the entirety of each tissue culture well (as described in
Figure 2.10) supports this observation (Figure 2.9.B), right hand side).
All three populations underwent robust adipocyte differentiation and activated
comparably high levels of adipocyte-specific genes when treated with the standard
complete cocktail of adipogenic inducers (Figure 2.9.C). However, under minimal
adipogenic conditions, containing only a low concentration of insulin, ICAM1+ and
CD142+ cells differentiated efficiently into adipocytes (similar to that seen with complete
cocktail), whereas DPP4+ cells displayed very low adipogenic capacity (Figure 2.9.D).
ICAM1+ and CD142+ cells expressed adipocyte-specific genes at/near the levels
observed in primary adipocytes isolated from adipose tissue, while DPP4+ cultures
displayed little to no induction of these genes (Figure 2.9.E).
Classical features of mesenchymal progenitor cells include a capacity for
multilineage differentiation and high proliferative activity. We found that DPP4+ cells
proliferated at a higher rate than ICAM1+ or CD142+ cells (Figure 2.9.F). Furthermore,
the DPP4+ cell population displayed an enhanced competence for differentiation into
osteocytes, with higher induction of osteocyte-specific marker genes (Figure 2.9.G).
Altogether, these data identify DPP4+ cells as highly proliferative multipotent
progenitors possessing many properties attributed to mesenchymal stem cells. By
contrast, ICAM1+ and CD142+ cells are relatively restricted to the adipocyte lineage.
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Figure2.9: DPP4+ progenitors display enhanced proliferative and multilineage
differentiation capacity.
Cells were isolated by using the following FACS strategy: Lin− (CD45−, CD31−) cells were
stained with anti-DPP4, anti-ICAM1, and anti-CD142. Groups were gated as follows: CD142+
cells were selected first, followed by DPP4+ (CD142−, DPP4+) or ICAM1+ (CD142−, ICAM1+)
cells. (A) Phase contrast imaging of DPP4+, ICAM1+ and CD142+ cells 24 h after isolation. (B)
Bodipy staining of neutral lipid in adipocytes (Green) from cultures of isolated DPP4+, ICAM1+
or CD142+ from p12 BL-6 mice cells following exposure to control media. Quantification of
adipogenesis (Right) [n = 3-5, independent wells per condition]. (C and D) Bodipy staining of
adipocytes and quantification of adipogenesis in cell cultures from adult CD1 mice after exposure
to the complete adipogenic differentiation cocktail (C) or insulin only (min) (D) [n = 3 biological
replicates (BRs) per condition]. (E) mRNA levels of adipocyte-specific genes in cultures from (C)
and (D). Primary adipocytes (adipo) purified directly from adipose tissue were included for
reference. (F) Quantification of cellular growth (representative of 3 BRs). (G) mRNA levels of
osteocyte-specific genes in cultures exposed to osteogenic differentiation inducers (n = 5 BRs).
Statistical testing: not significant, P > 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. Dots
represent BRs unless otherwise indicated, and error bars indicate SEM. Scale bars, 50 mM.
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Figure 2.10: Adipogenesis quantification strategy.
Cells were stained for lipid droplets (Bodipy) and Nuclei (Hoechst 33342) and each well was
imaged in its entirety at 20x generating a 7x7 stitched grid for mouse studies or 10x/5x5 grid for
human studies. Stitched images were split into component channels. Nuclei (blue channel) were
quantified by applying Gaussian Blur (3 Sigma), thresholding, watershed segmentation, and
counting. Lipid accumulation was quantified by applying Gaussian Blur (2 Sigma), thresholding,
and quantification of total area above threshold. The adipogenic index of each well was assessed
by dividing total lipid area by total number of nuclei. All calculations were performed on a per
well basis.
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TGF-Beta signaling maintains DPP4+ progenitor cell identity
To identify pathways regulating the divergent activities of DPP4+ and ICAM1+
cells, we compared the bulk transcriptomes of freshly sorted DPP4+ cells and ICAM1+
cells via RNA sequencing. Gene ontology analysis identified enrichment of the antiadipogenic TGFβ and WNT signaling pathways in DPP4+ cells (Figure 2.11.A) (Ignotz
& Massagut, 1985; Ross et al., 2000). Indeed, numerous WNTs (Wnts 1, 10b, 16), BMPs
(Bmps 2, 6, 7), and TGFβ components (Tgfbr2, Tgfb2) are very highly enriched in DPP4+
cells (Figure 2.11.B).
To assess the importance of TGFβ signaling on DPP4+ cell activity, we treated
freshly isolated DPP4+ cells with either recombinant TGFβ or SB431542, a potent and
specific TGFβ receptor inhibitor (Figure 2.12.A-B). TGFβ-treatment induced the
expression of many Group 1 marker genes, including Dact2, Wnt10b, and Ptgs2 (Cox2),
while also suppressing Group 2 and adipogenic marker genes (Figure 2.12.B).
Conversely, TGFβ receptor inhibition had the opposite effect, including strongly
inducing Group 2 and adipocyte genes in DPP4+ progenitor cells (Figure 2.12.B).
At a functional level, TGFβ-treatment augmented the proliferation of DPP4+
cells, while TGFβ receptor antagonism suppressed proliferation down to the levels of
ICAM1+ cells (Figure 2.12.C). TGFβ-treatment inhibited adipocyte differentiation and
suppressed the induction of adipocyte-specific genes in DPP4+ cells exposed to the
complete induction cocktail (Figure 2.12.D-E) By contrast, TGFβ only mildly suppressed
the adipogenic conversion of ICAM1+ cells and exerted an intermediate inhibitory effect
on CD142+ cells (Figure 2.12.D-E). Reciprocally, inhibition of TGFβ signaling enhanced
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adipocyte differentiation of DPP4+ cells exposed to minimal adipogenic conditions but
had no observable effect on ICAM1+ or CD142+ cells (Figure 2.12.F-G). Thus, TGBβ
signaling regulates the identity and functional character of DPP4+ cells. Moreover, these
results show that ICAM1+ cells are especially refractory to the anti-adipogenic effects of
TGFβ, reinforcing the notion that, amongst the mesenchymal cell populations, ICAM1+
cells are the most highly committed to become adipocytes.
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Figure 2.11: DPP4+ cells display transcriptional upregulation of the TGF-Beta signaling
pathway.
(A) RNA-Seq and GO analysis of pathways enriched in FACS purified DPP4+ vs. ICAM1+ cells.
Combined score = log p-value multiplied by z-score of deviation from expected ranking. (B)
Volcano plot of statistical significance versus fold change between DPP4+ and ICAM1+ cells
demonstrating the most differentially expressed genes.
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Figure 2.12: TGFβ regulates the proliferation and adipogenic differentiation competency of
multipotent DPP4+ progenitors.
(A) Model of experimental paradigm for panels B and C. (B) mRNA levels of group 1, group 2,
and adipocyte (adipo) marker genes in DPP4+ cells treated with vehicle control, TGFb, or the
TGFb receptor inhibitor SB431542 (n = 4 BRs). (C) Quantification of cell growth in cultures
treated with TGFb or SB431542 (representative of 3 BRs). (D) Bodipy staining of adipocytes
(green) differentiated with the complete induction cocktail with or without TGFb treatment.
Relative adipogenesis is the adipogenic index of TGFb-treated cells relative to that of control
cells (right) (n = 3 BRs). (E) Fold changes in mRNA levels of adipocyte-specific genes in
cultures from (D). (F) Bodipy staining of adipocytes (green) and quantification of differentiation
in the indicated cultures (right) (n = 3 BRs). Relative adipogenesis is the adipogenic index of
SB431542-treated cells (SB cpd) relative to that of control cells. Min, minimal cocktail (insulin
only). (G) Adipocyte-specific mRNA levels in cultures from (F), displayed as fold change in
treated cells relative to control cells. Scale bars, 50 mM. Statistical testing: not significant (ns), P
> 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. Dots represent BRs, and error bars
indicate SEM.
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DPP4+ progenitors produce ICAM1+ and CD142+ preadipocytes
To determine the in vivo fate of DPP4+, ICAM1+, and CD142+ cells in adipose
tissue, we transplanted mTomato-expressing DPP4+, ICAM1+ or CD142+ cells into the
developing fat pads of wildtype animals (Figure 2.13, Figure 2.14). Flow cytometry
analyses of stromal cells isolated from recipient animals showed that DPP4+ cells
acquired ICAM1 and CD142 expression as early as day 7 post-transplant, and a subset of
the implanted cells downregulated DPP4 expression by day 14 (Figure 2.13.A, Figure
2.14.A). Transplanted ICAM1+ cells acquired expression of CD142 but did not produce
significant numbers of DPP4+ cells (Figure 2.13.B, Figure 2.14.B). Transplanted
CD142+ cells did not acquire DPP4 expression but a subset of these cells downregulated
CD142 and retained ICAM1 expression (Figure 2.13.C). Histologic examination of the
transplants after 50 days revealed robust development of mTomato+ mature adipocytes
from DPP4+, ICAM1+ and CD142+ cells (Figure 2.13.A-C, right panels). These results
demonstrate that DPP4+ cells act as progenitors for both ICAM1+ and CD142+ cells,
with these populations further differentiating into mature adipocytes. Moreover, the
results suggest that CD142+ and ICAM1+/CD142- cells interconvert in vivo. This led to
the development of the model presented in Figure 2.15.

DPP4+ progenitors reside in the reticular interstitium
Finally, given the divergent genetic and functional properties of DPP4+ and
ICAM1+ cells, we examined the anatomic relationship of these populations by
immunofluorescent staining for DPP4 and PREF1. PREF1 is another marker of Group 2
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(ICAM1+) cells in developing adipose tissue that was also previously defined as a preadipocyte marker (Figure 2.1) (Smas & Sul, 1993). Histological examination of
transverse sections of iWAT from 2-day-old pups revealed a striking anatomic
partitioning of DPP4+ (Group 1) and PREF1+ (Group 2) cells (Figure 2.16). PREF1+
cells were intercalated between mature adipocytes, distributed throughout the central
body of the iWAT. By contrast, DPP4+ cells were localized in the reticular interstitium
(RI) (Figure 2.16, inset 2), a recently appreciated fluid-filled network of collagen and
elastin fibers, which encases many organs, including adipose depots (Benias et al., 2018).
Many cells co-expressing DPP4 and PREF1 were found at the leading edge of p2 iWAT,
potentially representing DPP4+ cells in the process of transiting to ICAM1+ cells during
adipogenesis (Figure 2.16, inset 1). At even earlier stages of development, double
positive cells were more prominent throughout the body of the nascent iWAT depot
(Figure 2.17). Staining in adult murine adipose tissue for DPP4 along with other Group 1
markers ANXA3 and CD55 shows a similar localization of these cells in the RI (Figure
2.18). Previous reports show that preadipocytes and CD142+ cells occupy a perivascular
niche, an anatomically distinct structure with a similarly collagen-rich extracellular
matrix (Schwalie et al., 2018; W. Tang et al., 2008; Vishvanath et al., 2016). Notably,
DPP4+ interstitial progenitors are excluded from the perivascular compartment and lack
the expression of classic pericyte markers (Figure 2.19). A schematized model of the
locations of these cell types is presented in Figure 2.20.
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Figure 2.13: DPP4+ progenitors give rise to ICAM1+, CD142+ cells and mature adipocytes
in vivo.
(A) Sort-purified CD142(−), DPP4(+) and (B) CD142(−), ICAM1(+) cells from mTomato(+)
donor mice were analyzed before transplantation (day 0) (left) into the subcutaneous adipose of
10-day-old mTomato(−) recipientmice.Seven and 14 days after transplantation,mTomato(+) cells
were recovered and analyzed for the expression of DPP4, ICAM1, and CD142 (shown is one
representative transplant from n=4BRs). Fifty days after transplantation, mTomato+ cells were
visualized by immunofluorescence in recipient iWAT (right) (representative image; n = 3 to 4
BRs). AF, autofluorescence (525/50 nM) showing host adipocytes. (C) Sort-purified CD142(−)
cells were analyzed 14 days posttransplant for the expression of DPP4, ICAM1, and CD142
(shown is one representative transplant from n = 4 BRs).The left FACS plot depicts the CD142positive gate, and the right FACS plot shows analysis of cells from the CD142-negative gate.
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Figure 2.14: Transplant experiment replicates showing DPP4+ progenitor cells give rise to
ICAM1+ and CD142+ cells in vivo.
(A) Sort-purified CD142(-);DPP4(+) and (B) CD142(-); ICAM1(+) cells from mTomato(+)
donor mice were transplanted into the subcutaneous adipose of 10-day-old mTomato(-) recipient
mice. Seven and 14 days after transplantation, mTomato(+) cells were recovered and analyzed for
expression of DPP4, ICAM1, three additional biologic replicates are shown for each time point.
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Figure 2.15: Model of progenitor cell lineage hierarchy in adipose tissue.
Model depicting the lineage hierarchy relationships of the indicated cell types. DPP4+ cells are
able to produce both ICAM1+ and CD142+ cells and this process is unidirectional. ICAM1+ and
CD142+ cells can interconvert. Both ICAM1+ and CD142+ cells can produce adipocytes, though
it is unclear if this process is direct or requires conversion to one of the cell types first. TGF-beta
potently suppresses progression of DPP4+ cells toward the ICAM1+ and adipocyte phenotype.
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Figure 2.16: DPP4+ progenitors reside in the reticular interstitium.
Full-thickness flank tissue from a 2-day-old mouse pup was crosssectioned. Murine skin and
adipose were stained with hematoxylin and eosin (H&E) with labels localizing the dermis (D),
dermal fibroblasts (DF), the panniculus carnosus (PC), the RI, and adipocytes (Ad). Anti-DPP4
(red), anti-PREF1 (green), and DAPI (blue) were used for immunofluorescence. (Inset 1)
Magnification of the leading edge of the developing iWAT. (Inset 2) Cross-sectional
magnification of the body of the iWAT. Arrows show examples of DP (DPP4+, PREF1+) cells.
The arrowheads point to DPP4+, PREF1(−) cells.
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Figure 2.17: DPP4+ progenitors reside in a distinct anatomic niche.
DPP4+ progenitor cells reside in a distinct anatomic niche. (A) Full thickness flank tissue from a
newborn (p0.5) mouse pup was cross-sectioned at the indicated positions (a and b, upper left). (B)
H&E staining of murine skin and adipose with labels localizing: Dermis (D), Dermal Fibroblasts
(DF), panniculus carnosus (PC), reticular interstitium (RI), adipocytes (Ad), lymph node (LN) .
(C) Immunofluorescence using anti-DPP4 (Red, Group 1), anti-PREF1 (Green, Group 2), DAPI
(nuclei, blue). Inset 1: magnified view of the leading edge of the developing WAT; inset 2 =
cross-sectional magnification of the body of the iWAT; inset 3 = magnification through the body
of the nascent iWAT depot. Arrows show examples of DP (DPP4+; PREF1+) cells, Arrowhead
points to DPP4+;PREF1(-) cell.
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Figure 2.18: Group 1 markers (DPP4, ANXA3, and CD55) stain progenitor cells that reside
in the reticular interstitium of adult mice.
Full thickness flank tissue (iWAT) from adult C57/BL-6J mice was cross-sectioned. H&E
staining of murine skin and adipose with labels localizing dermis D, panniculus carnosus PC,
reticular interstitium RI, adipocytes A (top right panel). Immunofluorescence using anti-DPP4
(red, top left panel), anti-Anxa3 (green, middle left panel), and anti-CD55 (green, bottom left
panel). Double-staining using anti-DPP4 plus Anxa3 (middle right panel), and anti-CD55 (bottom
right panel) depicting co-expression in yellow. Individual gene expression t-SNE plots for each
gene are provided for reference to the left. Scale bars = 100μM
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Figure 2.19: DPP4+ interstitial progenitors do not occupy the perivascular space.
(A) H&E staining of adult murine subcutaneous iWAT. A = artery, V = vein, C = capillary, RI =
reticular interstitium. (B) Adult murine iWAT stained with anti-DPP4 (red), anti-PECAM1
endothelial cells (green), antiSMA smooth muscle cells (white), and DAPI nuclei. Yellow
arrowheads outline the lumen of arterioles reproduced at higher magnification in inset 1 and 2.
(C) Single cell violin plots, showing the mean and variance in expression density of smooth
muscle cell and pericyte marker genes across all the single-cell groups identified in p12 SVF. (D)
Single cell tSNE plots depicting the expression pattern of pericyte markers.
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Figure 2.20: Model of progenitor cell localization in developing adipose tissue.
Model depicting the anatomical relationships of the indicated cell types at the leading edge of
developing adipose tissue. As the tissue expands, progression of DPP4+ cells down the adipocyte
lineage occurs at the junction of the tissue and the reticular interstitium. Here, DPP4+ cells
convert to DPP4+/ICAM1+ cells and eventually to ICAM1+ committed preadipocytes which
subsequently develop into adipocytes.
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Comparison of our cellular subpopulations to those identified by other groups
This study identified and functionally assessed three major mesenchymal cell groups
in murine adipose: Group 1 DPP4+ ‘interstitial progenitor cells’ (IPCs); Group 2
ICAM1+ ‘preadipocytes’ and Group 3 CD142+/Clec11a+ cells. Recent reports by other
groups using similar methods have also profiled the progenitor cells residing in tissue
depots (Burl et al., 2018; Hepler et al., 2018; Schwalie et al., 2018). We therefore sought
to compare the cellular populations seen in these studies to those identified in this work.
For each of these three works, we determined: 1) The cellular subpopulations they
observed and 2) the cluster defining genes for each cellular subpopulation. We then
mapped these cluster defining genes onto our adult mouse inguinal fat single cell RNA
sequencing data (Figure 2.4) to determine whether their populations comported with ours.
Overall, this analysis indicates that each of our studies identified analogous cell groups,
signifying that these cell populations are present across a wide variety of adipose sources
from animals of different ages and metabolic status (Figures 2.21, 2.22, 2.23). This high
overall concordance between studies highlights the robustness of single-cell RNA-Seq
technology and strengthens the notion that the identified cell groups represent a general
paradigm for adipose progenitor biology.
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Figure 2.21: Comparison to Burl et al.
The top 20+ cluster-defining genes reported by Burl et al. for their ASC1 (top) and ASC2
(bottom) populations are overlaid on the adult mouse single-cell RNA-Seq data and group
identities depicted in Fig. 1A.
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Figure 2.22: Comparison to Hepler et al.
The top 20 cluster-defining genes reported by Hepler et al for their FIP (top left), APC (top right)
and Committed Preadipocyte (bottom) populations are overlaid on the adult mouse single-cell
RNA-Seq and group identities depicted in Fig. 1A
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Figure 2.23: Comparison to Schwalie et al.
The top 10-20 cluster-defining genes reported by Schwalie et al. for their P1 (top left), P2 (top
right) and P3-‘Areg’ (bottom) populations are overlaid on the adult mouse single-cell RNA-Seq
and group identities depicted in Fig. 1A.
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2.1

Discussion
This work defines a developmental hierarchy of adipose progenitors, active during

early murine adipogenesis, which may be a general paradigm for adipogenesis in both
mice and humans. In young animals, DPP4+ interstitial progenitors produce CD142+
cells and ICAM1+ preadipocytes that are poised to differentiate into adipocytes (Figure
2.15). We speculate that, in adults, DPP4+ cells undergo adipose lineage commitment in
response to various stimuli, providing a renewable source of preadipocytes.
It is also conceivable that other cell populations in adult adipose depots, including
ICAM1+ or CD142+ cells residing within the perivascular niche, mediate tissue turnover
and remodeling without further contribution from DPP4+ cells. Future genetic lineage
tracing studies will ascertain if DPP4+ cells are the major or exclusive progenitor source
of adipocytes during development and in adult animals. Furthermore, the identification of
functionally distinct precursor populations will inform the development of more targeted
approaches to promote metabolically beneficial hyperplastic adipose tissue growth. A
particularly significant finding from this work is that adipose progenitor cells reside in a
previously unrecognized anatomic niche (Figure 2.20). The reticular interstitium is a
large tissue that surrounds many organs, but has not been well studied. Our results raise
the possibility that the RI, in addition to serving as a reservoir for adipocyte progenitor
cells in fat depots, plays important roles in the development and regeneration of other
tissues.
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CHAPTER 3: The Properties of DPP4+, ICAM1+, and CD142+ Cells in
Other Adipose Tissue Depots and Under External Stress

The first half of this chapter is adapted from: Merrick, David., Sakers, Alexander.,
Irgebay, Zhazira., Okada, Chihiro., Calvert, Catherine., Morley, Michael P., Percec,
Ivona., Seale, Patrick. Identification of a mesenchymal progenitor cell hierarchy in
adipose tissue. Science (80-. ). 364, eaav2501 (2019). (Merrick et al., 2019)
The second half of this chapter, analysis of the response of adipocyte progenitor cells to
cold exposure, is unpublished and was performed independently.
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3.1

Abstract
Adipose tissue is a highly plastic organ that found in multiple locations

throughout the body. These depots have critical roles in responding to the external
stressors of overnutrition and of cold exposure which require the generation of new white
adipocytes and new thermogenic beige adipocytes respectively. Previous work defined a
lineage hierarchy in subcutaneous adipose tissue in which DPP4+ interstitial progenitor
cells are the common progenitors to ICAM1+ committed preadipocytes and CD142+
group 3 cells. Here, we show that the cell types in this lineage are found throughout the
major adipose depots in mice, including visceral white fat, subcutaneous white fat, and
interscapular brown fat. Additionally, we show that during diet induced obesity, there is
depletion of the DPP4+ progenitors and a reduction of the adipogenic capacity of all
progenitor cells in visceral adipose tissue. These findings suggest that exhaustion of the
adipocyte progenitors, specifically DPP4+ cells, may play a role in the pathogenesis of
obesity induced metabolic disease. Finally, we show that in the subcutaneous fat, a short
duration of cold exposure is sufficient to upregulate transcriptional signatures of
adipocyte differentiation in each population. We did not find evidence for a specialized
committed beige preadipocyte and suggest that all three populations may be part of the
both the beige and white adipocyte lineage. Taken together this work suggests that the
lineage hierarchy between DPP4+, ICAM1+, and CD142+ cells is a general feature of
adipose tissue and suggests a key role for DPP4+ cells in the response to overnutrition.
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3.2

Introduction
Adipose tissue is organized into numerous discrete depots distributed throughout

the body, each of which have distinctive characteristics and specialized roles in normal
physiology (Jong, Larsson, Cannon, & Nedergaard, 2015). Mammals have three types of
adipose: white, beige, and brown (Cannon & Nedergaard, 2004). White adipose is the
most abundant form and serves as a lipid storage and endocrine organ. Brown and beige
adipocytes are specialized to expend energy in the form of heat (Cannon & Nedergaard,
2004). Brown adipocytes develop during embryogenesis from a shared lineage with
muscle (BAT)(Seale et al., 2008, 2007). Beige adipocytes develop in response to cold or
beta-adrenergic stimulation within white adipose depots (Young et al., 1984). Beige
adipocytes appear to have the ability to develop both from pre-existing “white”
adipocytes and from de novo adipogenesis (Roh et al., 2018; Rosenwald et al., 2013;
Rosenwald & Wolfrum, 2014; Q. A. Wang et al., 2013; W. Wang et al., 2014).
The major adipose depots in mice include the visceral (gonadal) white fat, the
interscapular brown fat, and the subcutaneous inguinal and axillary white fat (Jong et al.,
2015). These depots are roughly analogous to the visceral, subcutaneous, and brown
adipose depots found in humans (Schoettl, Fischer, & Ussar, 2018). The visceral fat
serves important roles in the contexts of fasting/refeeding and starvation/overnutrition. In
particular, the behavior of the visceral fat in response to chronic overnutrition is of great
scientific and public health interest due to the association of visceral obesity with the
development of type II diabetes and metabolic disease (Fox et al., 2007; N. B. Ruderman
et al., 1981; N. Ruderman et al., 1998).
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In mice, the visceral fat responds the most dynamically to fasting. During a fast,
the visceral adipose depots lose 30-50% of their mass by 24 hours while it takes up to 48
hours for the subcutaneous depots to do the same (H. Tang et al., 2017). In the setting of
chronic overnutrition, the visceral (epididymal) fat expands first via hypertrophy of preexisting adipocytes and later (after about 5 weeks) via the formation of new adipocytes,
i.e. hyperplasia (Jeffery et al., 2015; Q. A. Wang et al., 2013).
In contrast, the subcutaneous adipose tissue expands primarily through
hypertrophy, without appreciable de-novo adipogenesis (Jeffery et al., 2015; Q. A. Wang
et al., 2013). These effects correlate with a burst of proliferation observed in the
precursor cells of visceral but not of subcutaneous adipose tissue during high fat feeding
(Jeffery et al., 2015). The differences in the modes of expansion between these two
depots raises the possibility that their resident precursor cells may be responding to
overnutrition in fundamentally different ways.
Chapter 2 showed that the precursor compartment of mouse inguinal adipose
tissue contains three major, functionally distinct cell types, DPP4+ “interstitial
progenitors”, ICAM1+ “committed preadipocytes”, and CD142+ “group 3” cells. It is
therefore important to ascertain whether these cell types represent a general feature of
adipose tissue or are restricted to just the inguinal subcutaneous fat. Additionally, the
inguinal fat undergoes significant remodeling during two physiologic scenarios: cold
exposure and diet induced obesity. In light of the findings of chapter 2, we sought to
determine how the different precursor subtypes respond to these commonly encountered
exogenous stressors.
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Much work has focused on identifying the origins of beige adipocytes, including
whether a so-called “beige” preadipocyte exists and whether it is a distinct cell type from
“white” preadipocytes (D. C. Berry et al., 2016; Rosenwald et al., 2013; Rosenwald &
Wolfrum, 2014; W. Wang et al., 2014). Such a distinction would imply that there are
progenitor cells within white adipose tissue depots that are committed to become UCP1+
thermogenic beige adipocyte rather than white adipocytes. Alternatively, both white and
beige adipocytes may arise from the same pool of progenitors. Under this model,
different signals received post-commitment, i.e. during the course of adipogenesis, would
be responsible for whether the progenitor develops into a white or a beige adipocyte. We
sought to test this model in the proceeding chapter. Overall, netter understanding of the
mechanisms by which the precursor cells function during the generation of metabolically
beneficial beige adipocytes and how they are altered during adipose tissue expansion may
yield promising insights into how to treat metabolic disease.
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3.3

Results

Analogous populations of DPP4+, ICAM1+, and CD142+ cells are found in all major
adipose tissue depots
Previous work showed that DPP4+, ICAM1+, and CD142+ cells are distinct
adipogenic precursor subtypes each with unique functional properties found in the
inguinal adipose tissue. We sought to determine if these precursor subtypes were found
within the other major adipose tissue depots of the body, namely, the subcutaneous
axillary WAT (axWAT), the visceral epididymal WAT (eWAT), and the interscapular
BAT (iBAT) (Figure 3.1). Flow cytometry analysis showed that the three major
mesenchymal cell populations (DPP4+, ICAM+, CD142+) identified in iWAT were also
present in subcutaneous axillary WAT, interscapular brown adipose tissue and visceral
epididymal WAT of adult mice (Figures 3.2, 3.3, and 3.4). Of note, the relative
proportion of DPP4+ cells was much lower in visceral WAT compared to subcutaneous
depots (iWAT or axWAT) (Figures 3.2, 3.3, and 3.4). The cell populations isolated from
axWAT, eWAT, and BAT displayed the same pattern of adipogenic and proliferative
activity as those from iWAT (Figures 3.2, 3.3, and 3.4). Regardless of their depot of
origin, ICAM1+ cells had greater adipogenic competence and were more resistant to the
inhibitory effects of TGFβ when compared to DPP4+ cells (Figures 3.2-3.4and Figure
2.12). Together, these results suggest that DPP4+, ICAM1+ and CD142+ mesenchymal
cells have conserved roles in all the major adipose depots.
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Figure 3.1: Anatomic locations of major mouse adipose depots.
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Figure 3.2: Relative population abundance and adipogenic capacity of DPP4+, ICAM1+
and CD142+ cells isolated from axillary adipose tissue.
(A) FACS plot of representative subcutaneous axillary white adipose tissue (axWAT) SVF from
pooled adult CD1 mice (left). Quantification of relative population abundance (right) (n = 3
BR/group). (B) Quantification of adipogenesis via adipogenic index (from Bodipy and Hoechst
staining) upon induction with complete adipogenic cocktail (n = 3 BR/group). (C) Quantification
of relative adipogenesis upon induction with complete cocktail plus TGFβ1 compared to
complete cocktail treated controls (Right). (n = 2-3 BR/group). (D) Quantification of
adipogenesis (from Bodipy and Hoechst staining) upon induction with minimal (insulin only)
adipogenic cocktail (n = 3 BR/group).
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Figure 3.3: Relative population abundance and adipogenic capacity of DPP4+, ICAM1+
and CD142+ cells isolated from visceral adipose tissue.
(A) FACS plot of representative visceral epididymal white adipose tissue (eWAT) SVF from
adult CD1 mice (left). Quantification of relative population abundance (right) (n = 3 BR/group).
(B) Quantification of adipogenesis via adipogenic index (from Bodipy and Hoechst staining)
upon induction with complete adipogenic cocktail (n = 3 BR/group). (C) Quantification of
relative adipogenesis upon induction with complete cocktail plus TGFβ1 compared to complete
cocktail treated controls (Right). (n = 2-3 BR/group). (D) Quantification of adipogenesis (from
Bodipy and Hoechst staining) upon induction with minimal (insulin only) adipogenic cocktail (n
= 3 BR/group). (E) Quantification of relative adipogenesis upon induction with minimal cocktail
+ SB431542 compared to minimal cocktail treated control (n = 3 BR/group).
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Figure 3.4: Relative population abundance and adipogenic capacity of DPP4+, ICAM1+
and CD142+ cells isolated from brown adipose tissue.
(A) FACS plot of representative interscapular brown adipose tissue (iBAT SVF from adult CD1
mice (left). Quantification of relative population abundance (right) (n = 3 BR). (B) Quantification
of adipogenesis via adipogenic index (from Bodipy and Hoechst staining) upon induction with
complete adipogenic cocktail (n = 3 BR/group). (C) Quantification of relative adipogenesis upon
induction with complete cocktail plus TGFβ1 compared to complete cocktail treated controls
(Right). (n = 2-3 BR/group). (D) Quantification of adipogenesis (from Bodipy and Hoechst
staining) upon induction with minimal (insulin only) adipogenic cocktail (n = 3 BR/group). (E)
Quantification of relative adipogenesis upon induction with minimal cocktail + SB431542
compared to minimal cocktail treated control (n = 3 BR/group).
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Reduced activity of visceral progenitors during obesity
We next examined the responses of these cell populations to adverse metabolic
conditions. DPP4+, ICAM1+ and CD142+ cells were isolated from ~16-week-old dietinduced obese mice. These mice weighed significantly more than age and strain matched
chow-fed controls and were glucose-intolerant, making them a good model of human
obesity with insulin resistance (Figure 3.5.A). The visceral eWAT from obese animals
had a lower proportion of DPP4+ cells and an increased proportion of CD142+ cells
when compared to lean controls (Figure 3.5.B). Interestingly, ICAM1+ and CD142+ cells
from the visceral depot of obese mice were less proliferative and had lower adipogenic
differentiation capacity than corresponding cells from lean control animals (Figure
3.5.C,D). Notably, these effects were apparent under minimal adipogenic conditions,
suggesting that the defects in adipogenesis are mild enough that they can be overcome
with stronger adipogenic stimulation.
By contrast, in the subcutaneous WAT there were not significant changes in the
abundance of each cellular subtype (Figure 3.6.A). Furthermore, ICAM1+ and CD142+
cells from the subcutaneous iWAT of obese mice retained high proliferative and
adipocyte differentiation competency (Figure 3.6.B,C). These results imply that high fat
feeding and/or obesity depletes the DPP4+ mesenchymal progenitor pool and impairs the
adipogenic differentiation competency of pre-adipocytes, specifically in visceral WAT. A
model postulating how selective differentiation of the precursors with the greatest
adipogenic capacity may explain these findings is presented in Figure 3.7.
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Figure 3.5: Obesity reduces the adipogenic capacity of visceral WAT ICAM1+ and CD142+
cells.
(A) Glucose tolerance test (GTT) (left) and weight of diet-induced obese (DIO) vs lean control
mice used in panels B-G (n =4/group lean, n=17/group DIO). (B) Representative FACS plot of
epididymal white adipose tissue (eWAT) SVC from lean (left) and DIO animals (middle).
Quantification of population abundance (right) (n =3 BR/group). (C) Quantification of cellular
growth (representative of 3 BR). (D) Quantification of adipogenesis (Bodipy staining) upon
induction with complete adipogenic cocktail (left), or with minimal cocktail (right). (n = 3
BR/group). Statistical Testing: NS p>0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.
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Figure 3.6: The adipogenic capacity of subcutaneous WAT ICAM1+ and CD142+ cells is
augmented in obesity.
Diet-induced obese (DIO) vs lean control mice used in panels A-C (n =4/group lean, n=17/group
DIO). Analysis of subcutaneous adipose tissue from the same cohort of mice in figure UE. (A)
Representative FACS plot of inguinal WAT SVC from lean (left) and DIO animals (middle) (n=3
BR/group). Quantification of population abundance (right) (n=3 BR/group). (B) Quantification of
cellular growth (representative of 3 BR). (C) Quantification of adipogenesis upon induction with
complete (left) or minimal (insulin) adipogenic cocktail (n = 3 BR/group). Statistical Testing: NS
p>0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.
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Figure 3.7: Model of progenitor response to diet induced obesity in visceral and
subcutaneous WAT.
In visceral WAT, diet induced obesity induces adipogenesis and high amounts of lineage
progression going from DPP4+ cells (blue) through ICAM1+ (red) / CD142+ (green) cells and
finally to adipocytes. The cells that remain after this stimulus are likely to be the most insulin
resistant and least adipogenic cells. In contrast, in the subcutaneous WAT, diet induced obesity
induces little adipogenesis or lineage progression. There is no depletion of DPP4+ cells and the
progenitor compartment displays enhanced competency for in vitro adipogenesis, perhaps
representing compensation for the depletion of the visceral precursor pool.
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Cold exposure induces transcriptional features of adipocyte differentiation in all
precursor subpopulations
We performed single cell RNA sequencing on the SVCs of adult mice exposed to
1 day of cold to attempt to identify committed beige preadipocytes. We hypothesized that
this short period of cold exposure would reveal new adipocyte progenitor cell subtypes
(potentially including beige preadipocytes) not present in the thermoneutral adult dataset
(presented in Chapter 2).
Single cell RNA-Seq of 1 day cold exposed SVCs identified ten groups (Figure
3.8.A). Consistent with both the thermoneutral adult and p12 pup datasets, there were
three prominent mesenchymal populations, which we identified as DPP4+, ICAM1+, and
CD142+ cells (Groups 1-3 respectively) (Figure 3.8.A). These results were nearly
identical to what was observed in the adult thermoneutral dataset, and similar to what was
observed in the p12 pup dataset (Figures 2.1 and 2.4).
Notably, the cold exposed mice showed a greater proportion of group 3 / CD142+
cells than the thermoneutral mice (Figure 3.8.A and Figure 2.4.A). As expected, smooth
muscle cells (group 4), endothelial cells (group 5), and Schwann cells (group 10) were all
identified based on the markers discussed previously (Figure 3.8.A). As in the
thermoneutral dataset, immune cells were included in this experiment; populations of Tcells (Cd45+, Cd3d+), B cells (Cd45+, Cd19+), macrophages (Cd45+, Cd68+), and
dendritic cells (Cd45+, Ccl5+), were all identified (Wetzels et al., 2018). Overall, the
identified cellular populations and the genes that define them were highly similar
between the thermoneutral and cold exposed groups (Figure 3.8.B-C). Importantly, no
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populations could be identified which expressed Ucp1, the defining gene for beige
adipocytes. No new cellular groups were identified, refuting our hypothesis that a new
population of preadipocytes would appear in the cold (Figure 3.8.A-C).
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Figure 3.8: Single cell sequencing of adult mice exposed to brief cold.
(A) Single cell tSNE plots of SVF from an adult mouse exposed to 24hrs of cold exposure (6 ◦
C). Expression of selected genes from the literature (mesenchymal stem cell markers, gray box, ),
and from Supplemental Figure 1B (Group 1 genes, blue box; Group 2 genes, red box; Group 3
genes; smooth muscle, pink box; endothelial cells, green box; Macrophage/Dendritic/T-Cell/Bcell, purple boxes) are highlighted. (B) Violin plots showing the mean and variance in expression
density across all the groups identified. Selected marker genes for each group and from the
literature are highlighted.
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Given that there were minimal shifts in the composition of the precursor
compartment upon cold exposure and no new groups were identified we hypothesized
that beige adipocytes may arise directly from the DPP4+, ICAM1+, or CD142+ cells
already present in the tissue. We therefore performed bulk RNA sequencing on sorted
DPP4+, ICAM1+, and CD142+ cells from thermoneutral housed and 1 day cold exposed
adult mice to analyze more subtle changes in gene expression within these groups. Given
the unclear role of CD142+ cells in the tissue, we hypothesized that CD142+ cells may
be primed to become beige adipocytes, while ICAM1+ cells may be primed to become
white adipocytes.
FACS analysis indicated no significant shifts in the abundance of each group
upon cold exposure (Figure 3.9.A). Additionally, cold exposure induced relatively
modest changes in the gene expression of each of these groups (Figure 3.9.B). In the
aggregate, the major differentially expressed genes were derived from differences
between cell types rather than between cold exposed vs thermoneutral mice (Figure 3.9.C
and Figure 3.10). Previous work defined the major cluster defining gene sets for DPP4+,
ICAM1+, and CD142+ cells in mice (see Chapter 2). The expected cluster defining genes
were expressed in each cellular population, indicating that the sorting strategy used to
generate this dataset was valid (Figure 3.10). Given these relatively modest changes, we
examined the pairwise comparisons of Cold vs TN within each cell type (Figures 3.11,
3.12, 3.13).
In all cell populations, the cold and thermoneutral groups separated when
examined by principal component analysis (Figures 3.11.A, 3.12.A, 3.13.A). GO analysis
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of the pairwise comparisons revealed commonalities between DPP4+, ICAM1+, and
CD142+ cells in their response to cold. GO terms associated with adipocyte
differentiation such as “PPAR signaling pathway”, “fat digestion and absorption”, and
“regulation of lipolysis in adipocytes” terms were upregulated in the cold compared to
the TN cells (Figures 3.11.B, 3.12.B, 3.13.B). Conversely, cells at thermoneutrality
showed upregulation of extracellular matrix and fibrosis associated terms such as “TNF
signaling pathway”, “ECM-receptor interactions”, “Protein digestion and absorption”,
“focal adhesion”, and “HIF-1 signaling” (Figures 3.11.C, 3.12.C, 3.13.C). Notably,
“steroid hormone biosynthesis” and “thyroid hormone biosynthesis” also appear in these
comparisons. Where present, these are driven by upregulation of “Sult1e1 and SRD5A1”
and “Creb3l3 and Creb3l1” respectively. Sult1e1 (estrogen sulfotransferase) catalyzes the
sulfation of estrogen leading to its inactivation while SRD5A1 (steroid 5 alpha reductase
1) converts testosterone to the more active dihydrotestosterone (Marra, 2014). Creb3l3
and Creb3l1 are cAMP responsive binding protein 3- like proteins 1 and 3 respectively;
there role here is unknown but they are present in multiple tissues and are unlikely to be
involved in thyroid hormone synthesis.
Given the apparent commonalities between the genes upregulated in cold vs
thermoneutral, we further analyzed the data to examine whether cold exposure leads to a
common response within each cellular subpopulation (Figure 3.14). To do so, we defined
genes as “upregulated” in a comparison if they had a log2FC >0.5 with and were
significant (FDR of 10%). We determined which genes were unique to DPP4, ICAM1, or
CD142 populations and which genes were common to all 3 (Figure 3.14.A). At
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thermoneutrality there were 108 genes commonly upregulated in all three cellular
populations. GO analysis on this gene set reveals the same terms as observed in the
pairwise comparisons, namely “protein digestions and absorption”, “protein processing in
the ER”, “ECM-receptor interaction”, “focal adhesion”. In the cold, there were 89 genes
that were commonly upregulated. Consistent with the pairwise comparisons GO analysis
on this gene set showed upregulation of “lipolysis in adipocytes”. “PPAR signaling
pathway”, and “Metabolic pathways”. The GO terms circadian entrainment and circadian
rhythm were driven by upregulation of Per2, Per3, Prkg1 (Figure 3.14.B).
None of these analyses clearly identified a unique response to cold exposure in
DPP4+, CD142+, or ICAM1+ cells. We looked at the expression patterns of select
adipocyte identity genes and thermogenic genes (Figure 3.15). As expected, adipocyte
identity genes showed lower expression in DPP4+ cells than in ICAM1+ or CD142+ cells
(Figure 3.15.A). There was strong upregulation of Fabp4, Plin, and Retn with cold
exposure in ICAM1+ and CD142+ cells. These results are consistent with cold exposure
inducing adipocyte differentiation of ICAM1+ and CD142+ cells. Examination of the
thermogenic program genes revealed paradoxically that Ucp1 expression was the highest
in DPP4 cells at baseline but that CD142+ cells showed the most dynamic upregulation
(i.e. largest fold change upregulation from warm to cold) (Figure 3.15.B). ICAM1+ cells
showed only a modest induction. The transcriptional coactivators Ppargc1a and
Ppargc1b were upregulated in all cold-warm comparisons but showed this pattern most
strongly in ICAM1+ cells. DPP4+ cells showed high levels of EBF2 and its repressor
ZFP423, while ICAM1+ and CD142+ cells showed low levels of each (Shao et al.,
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2016). Overall, these results do not clearly identify which precursor subset, if any is fated
to become beige adipocytes.
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Figure 3.9: Cold exposure induces minimal changes in DPP4+, ICAM1+, and CD142+ cells.
(A) Quantification of population abundance via FACS (n=3 BR/group) in cold exposed and
thermoneutral housed (TN) mice. (B) PCA plot of bulk RNA-sequencing data from FACS sorted
DPP4+, ICAM1+, and CD142+ cells from 1 day cold exposed and TN mice (n=3 BR/group). (C)
Heatmap of the most significant differentially expressed genes in freshly isolated DPP4+ (blue),
ICAM1+ (red) or CD142+ (green) cells from (B).
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Figure 3.10: Validation of FACS isolation strategy via bulk RNA sequencing.
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+, ICAM1+, and CD142+
cells from cold from thermoneutral (TN) housed and 1 day cold exposed mice. Heatmap of select
previously defined group identity genes for DPP4+, ICAM1+, and CD142+ (n=3BR/group).
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Figure 3.11: Response of DPP4+ cells to brief cold exposure.
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+ cells from thermoneutral
(TN) housed and 1 day cold exposed mice (n=3 BR/group). (A) PCA plot. (B) KEGG 2016 gene
ontology of genes upregulated (log2FC>1) by cold exposure. (C) KEGG 2016 gene ontology of
genes upregulated (log2FC>1) at thermoneutrality.
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Figure 3.12: Response of ICAM1+ cells to brief cold exposure.
Bulk RNA sequencing was performed on freshly FACS sorted ICAM1+ cells from thermoneutral
(TN) housed and 1 day cold exposed mice (n=3 BR/group). (A) PCA plot. (B) KEGG 2016 gene
ontology of genes upregulated (log2FC>1) by cold exposure. (C) KEGG 2016 gene ontology of
genes upregulated (log2FC>1) at thermoneutrality.
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Figure 3.13: Response of CD142+ cells to brief cold exposure.
Bulk RNA sequencing was performed on freshly FACS sorted CD142+ cells from thermoneutral
(TN) housed and 1 day cold exposed mice (n=3 BR/group). (A) PCA plot. (B) KEGG 2016 gene
ontology of genes upregulated (log2FC>1) by cold exposure. (C) KEGG 2016 gene ontology of
genes upregulated (log2FC>1) at thermoneutrality.
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Figure 3.14: Common upregulated genes sets at thermoneutrality and cold.
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+, ICAM1+, and CD142+
cells from thermoneutral (TN) housed and 1 day cold exposed mice. Upregulated genes were
defined as those with log2FC>0.5 within a given cell type when comparing cold to thermoneutral
conditions (n=3 BR/group). (A) Venn diagrams represent overlaps in upregulated genes at
thermoneutrality or in cold. (B) KEGG 2016 gene ontology analysis of genes commonly
upregulated in all 3 cell types at thermoneutrality or cold.
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3.15: Heatmap of select genes from thermoneutral and cold exposed DPP4+, ICAM1+, and
CD142+ cells.
Bulk RNA sequencing was performed on freshly FACS sorted DPP4+, ICAM1+, and CD142+
cells from thermoneutral (TN) housed and 1 day cold exposed mice. Heatmap of select previously
defined genes important for (A) general adipocyte identity or (B) thermogenesis (n=3BR/group).
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3.4

Discussion
The work presented here shows that the progenitor cell subtypes, DPP4+,

ICAM1+, and CD142+, identified in inguinal white adipose tissue are present in the
major adipose depots found in mice. Furthermore, in all depots DPP4+ cells were found
to be more proliferative, less adipogenic, and more TGFβ sensitive than ICAM1+ cells.
The identification of analogous cellular populations with similar function properties
indicates that the distinctions between DPP4+, ICAM1+, and CD142+ cells are likely to
be a general feature of all adipose tissue. Consistent with this, we anticipate that the
lineage hierarchy identified in chapter 2, in which DPP4+ cells are the common
progenitor to ICAM1+ and CD142+ cells, is also present within these tissues. Future
work should include lineage tracing and transplantation studies in these depots to test this
possibility.
The identification of the same types of progenitor cells across multiple locations
allowed us to ask how these cells behave under the stress of diet induced obesity in
different adipose depots. The most notable finding was the relative loss of progenitor cell
functionality in the visceral compartment. In agreement with Schwalie et al, we found
that there was a higher proportion of CD142+ cells in eWAT relative to iWAT and in
obese vs. lean adipose tissue (Figures 3.5 and 3.6). Such a finding suggests that
progenitor cell exhaustion and reduced precursor differentiation may contribute to the
pathologic remodeling of visceral WAT in obesity, which is linked to metabolic disease
progression. One possible explanation for these findings is that obesity induces cell
autonomous changes in precursor cell function. The other possibility is that in the context
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of the levels of high-adipogenesis in the visceral compartment, selection bias accounts for
the observed results (Figure 3.7). The model presented in figure 3.7 assumes there is a
stochastic distribution of adipogenic potential in the precursors before the onset of diet
induced obesity. In the visceral compartment, where there is high adipogenesis during
diet induced obesity, only the least adipogenic progenitors remain after prolonged caloric
excess (Q. A. Wang et al., 2013). In contrast, in the inguinal WAT where there is low
adipogenesis during diet induced obesity, such a selection process does not occur, and we
see maintenance of the functional capacity of the tissue resident progenitors. Future work
should focus on the mechanism by the visceral progenitor pool becomes exhausted and
less adipogenic in obesity.
Finally, we hypothesized that either ICAM1+ or CD142+ cells may be a
committed beige preadipocyte. Both single cell analysis and bulk RNA sequencing of
FACS sorted progenitor cells from cold exposed mice indicated that with 1 day of cold
exposure there are only relatively modest changes in the progenitor cell compartment.
Using scRNA-Seq no new populations were detected; via bulk RNA sequencing, we
observed that cold induced upregulation of components of adipocyte differentiation in all
populations. Examination of the bulk RNA sequencing data for the expression of select
thermogenic genes yielded a confusing picture. DPP4+ interstitial progenitors, the least
differentiated cells in the lineage hierarchy, paradoxically had the highest expression of
Ucp1, Ebf2, and Zfp423. CD142+ cells showed the greatest dynamic upregulation of
Ucp1. ICAM1+ cells showed the highest levels of Pparpgc1a and Pparpgc1b. Thus, the
transcriptional components of the thermogenic program do not appear to be dynamically
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regulated in a specific population. Given the short duration of cold exposure, it is possible
that these analyses were performed too early in the process of cold-induced tissue
remodeling. Therefore, future work should employ similar techniques to those used here
to determine the precise time course and nature of the cold response in these progenitor
cells.
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CHAPTER 4: Adipocyte Progenitor Cells in Human Adipose Tissue
Adapted from: Merrick, David., Sakers, Alexander., Irgebay, Zhazira., Okada,
Chihiro., Calvert, Catherine., Morley, Michael P., Percec, Ivona., Seale, Patrick.
Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science (80-.
). 364, eaav2501 (2019). (Merrick et al., 2019)
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4.1

Abstract
Adipose tissue plays a central role in coordinating systemic metabolism. In the

context of overnutrition, the capacity for fat to expand to store excess calories protects
the body from inappropriate lipid deposition in other organs. The identities of the
progenitor cells responsible for the formation of new adipocytes in human fat remained
unknown. Previous work showed that the progenitor cells in mouse adipose tissue are
organized into a lineage hierarchy containing DPP4+ interstitial progenitors which are the
common precursor to ICAM1+ committed preadipocytes and CD142+ cells. We
therefore examined whether human adipose tissue is similarly organized. We developed a
FACS based strategy for isolating these cells from humans and found similar populations
of DPP4+, ICAM1+, and CD142+ cells. Functional assays and single cell RNA
sequencing demonstrated that DPP4+ and ICAM1+ cells from human exhibited similar
properties and gene expression patterns to those from mice. However, unlike in mice,
CD142+ cells are not a distinct population. Overall this work suggests the progenitors in
human adipose tissue is organized into a two-component linear hierarchy containing
DPP4+ interstitial progenitors and ICAM1+ committed preadipocytes. These findings lay
the groundwork for future studies examining how these different progenitor populations
may be targeted to treat metabolic disease.
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4.2

Introduction
The previous chapters have demonstrated that the progenitor cells in murine

adipose tissue are organized into a lineage hierarchy in which DPP4+ interstitial
progenitors are the common precursor to ICAM1+ committed preadipocytes and to
CD142+ cells. These cells are found throughout all major mouse adipose tissue depots,
but it remained unknown if analogous populations were present in human adipose tissue.
Human and mouse adipose tissue have important similarities which makes
studying the properties of mouse adipose tissue relevant to human biology (Sharp et al.,
2012). For example, many of the same cell surface proteins used to isolate progenitors
from mouse adipose tissue are effective for the isolation of human progenitors (Hepler,
Vishvanath, et al., 2017; Jong et al., 2015; Raajendiran et al., 2019; Shao, Sun, et al.,
2018). However, important differences remain, especially: 1) Human adipose turns over
at a rate of about 8% per year while mouse tissue turns over faster, 2) mice have much
shorter lifespans (shorter than the lifespan of the average human adipocyte), and 3)
human subcutaneous adipose tissue forms a continuous subdermal sheet rather than
forming discrete depots (Spalding et al., 2008). Given these key differences, we sought to
examine whether the progenitor compartment of human adipose tissue is also organized
into analogous groups of DPP4+, ICAM1+, and CD142+ cells.
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4.3

Results

Human adipose contains analogous stromal populations to mice
An important question is whether analogous populations of adipose stromal cells
are present in humans when compared to mice. Chapter 2 identified DPP4+, ICAM1+,
and CD142+ populations as distinct groups of progenitors found in murine adipose tissue.
We therefore adapted the FACS sorting strategy employed previously to identify similar
populations in the adipose tissue from human donors.
Subcutaneous fat tissue was procured from eight healthy human donors
undergoing elective cosmetic surgery procedures (Figure 4.1). Compared to mouse
adipose tissue, human adipose contains many fewer progenitor cells per gram; to ensure
enough cells for downstream analysis, we procured fat from abdominoplasty (tummytuck) and back lift procedures. In these procedures, over 1kg of skin and subcutaneous fat
are removed en-bloc with minimal disruption of the tissue. In contrast to progenitors
isolated from liposuction procedures, which involves extensive shearing and cell death,
progenitors isolated from abdominoplasty procedures show high viability. Seven out of
the eight donors were female, and all were overweight or obese (Figure 4.1). These
statistics reflect the demographics of the predominantly female population who elects to
undergo these procedures. All donors were non-diabetic and had healthy kidney function.
Seven out of eight procedures yielded abdominal subcutaneous fat while one yielded
flank and back subcutaneous fat. Since the abdominal, flank, and back subcutaneous fat
depots are continuous in humans, these samples were considered equivalent.
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We used FACS to identify and purify DPP4+, ICAM1+ and CD142+ cells from
fresh subcutaneous adipose tissue of human subjects undergoing cosmetic plastic surgery
(Figure 4.2.A). In comparison to mouse, human adipose contained proportionally fewer
DPP4+ cells (Figure 4.2.B). Human DPP4+ cells, like their mouse counterparts,
displayed higher proliferative activity (Figure 4.2.C) and reduced potential to
differentiate into adipocytes relative to both ICAM1+ and CD142+ cells, especially under
conditions of minimal adipogenic stimulation (Figure 4.2.D-E). Activation of TGFβ
signaling profoundly inhibited adipocyte differentiation in human DPP4+ cells, while
having relatively less effect on ICAM1+ and CD142+ cells (Figure 4.3.A-B). Similarly,
treatment with TGFβ specifically augmented the proliferation of DPP4+ cells but not of
CD142+ or ICAM1+ cells (Figure 4.3.C-D).
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Figure 4.1: Demographics of human adipose tissue donors.
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Figure 4.2 Human adipose contains analogous populations of DPP4+ progenitors and
ICAM1+ preadipocytes.
(A) FACS isolation of cell populations from human adipose tissue (representative of eight
individual donors). Populations were purified as follows: Lin− (CD45−, CD31−) cells were
stained with anti-DPP4, anti-ICAM1, and anti-CD142. CD142+ cells were selected first, followed
by DPP4+ (CD142−, DPP4+) and ICAM1+ (CD142−, ICAM1+) cells. DP, double positive
(DPP4+, ICAM1+); DN, double negative (DPP4−, ICAM1−); FSC, forward scatter; k, thousand.
(B) Quantification of relative progenitor abundance from n = 8 human tissue donors. (C) Relative
proliferation rates of human cells (n = 5 donors). (D) Bodipy staining of adipocytes (green) in
cultures treated with complete (top) or minimal (insulin plus rosiglitazone) (bottom) induction
cocktail. (E) Quantification of adipogenic differentiation from cells shown in (D) (n = 6 donors).
Statistical testing: ns, P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. Dots
represent BRs, and error bars indicate SEM.
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Figure 4.3 Human DPP4+ and ICAM1+ cells display similar TGFβ responsiveness as the
analogous populations in mice.
(A) Bodipy staining of lipids (green) and Nuclei (Hoechst) in human cells treated with complete
human adipocyte differentiation medium +/- recombinant TGFβ1. (B) Quantification of
adipogenic differentiation from (A) (n = 6 BR/group). (C) Cellular growth of equal starting
numbers of human cells treated with recombinant TGFβ1 (One individual, representative of 5
BR). (D) Relative proliferation rates of human cells (n=5 human donors).
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CD142+ cells are not a distinct subpopulation in human subcutaneous adipose
In mice, ICAM1+ and CD142+ cells are similarly adipogenic but differ markedly
in their response to TGFβ; mouse ICAM1+ cells are resistant to the anti-adipogenic
effects of TGFβ while mouse CD142+ cells are sensitive (Figure 2.12). The lack of such
differences in humans led us to hypothesize CD142 was not identifying a distinct
population of cells in humans. Therefore, to investigate the heterogeneity of human
adipose stromal cells in an unbiased manner, we performed single cell expression
profiling of CD45-depleted SVCs from human abdominal subcutaneous WAT.
Clustering analysis of gene expression profiles identified 5 cell populations,
including 2 main groups of cells (Groups 1-2) that expressed mesenchymal markers
PDGFRa, PDGFRb and SCA1 (Figure 4.4.A-B). Group 1 cells selectively expressed
DPP4, CD55 and WNT2, analogous to murine Group 1 cells (Figures 4.4.A-B and 4.5).
Group 2 cells expressed ICAM1, PPARg and GGT5, comparable with mouse Group 2
cells. However, murine Group 3 markers CD142, CLEC11A and FMO2 were broadly
expressed across human groups 1 and 2 (Figures 4.4.A-B and 4.5). These data suggest
that human subcutaneous adipose tissue does not contain a distinct population of CD142+
cells. This conclusion concurs with the lack of functional differences between sorted
human ICAM1+ and CD142+ cells in our assays (Figures 4.2 and 4.3). Altogether, we
conclude that human and murine WAT contain comparable DPP4+ and ICAM1+ cell
populations with similar functional attributes.
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Figure 4.4: Human adipose tissue contains analogous populations of interstitial progenitors
and committed pre-adipocytes but not CD142+ cells.
(A) Unsupervised clustering of 11,338 cells (mean number of genes per cell = 1253) from the
abdominal subcutaneous adipose tissue of a 31-year-old female donor (body mass index, 31.6)
reveals five distinct cell groups represented on a tSNE map (relevant marker genes are in
parentheses). (B) Individual gene tSNE and violin plots showing the expression levels and
distribution of representative marker genes. The y axis is the log-scale normalized read count.
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Figure 4.5: Marker gene expression patterns across human adipose cell groups.
(A) Single cell tSNE plots of the stromal-vascular fraction from abdominal subcutaneous adipose
tissue of a 31-year-old female donor (BMI 31.6), highlighting the expression patterns of selected
genes from the literature (mesenchymal stem cell markers, gray box), and cluster-specific marker
genes. (B) Single cell violin plots, showing the mean and variance in expression density across all
the single-cell groups.
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4.4

Discussion
Chapter 2 defined the developmental trajectory for making an adipocyte and

showed that the progenitor cells within adipose tissue are organized into a lineage
hierarchy. The core components of this hierarchy were DPP4+ interstitial progenitors,
ICAM1+ committed preadipocytes, and CD142+/group 3 cells. The work presented here
suggests that human adipose tissue follows similar lineage dynamics, with some
important differences.
We show that populations of DPP4+, ICAM1+, and CD142+ cells can be
identified by FACS in human subcutaneous adipose tissue. However, functional assays
and single cell RNA sequencing fail to define CD142+ cells as a distinct group. Indeed,
in assays of adipogenic capacity, proliferation, and TGFβ sensitivity, human CD142+ and
ICAM1+ cells behaved identically (Figures 4.2 and 4.3). This is in stark contrast to what
was observed in mice, where CD142+ cells were highly adipogenic but also highly
susceptible to the anti-adipogenic effects of TGFβ signaling (Figure 2.12). Single cell
sequencing of human subcutaneous adipose tissue provided an explanation for these
results. CD142 does not identify a separate population of cells and instead is found on
both ICAM1+ and DPP4+ cells. Since there are more ICAM1+ cells in the tissue, using
CD142 as a FACS marker appears to have yielded a mixture containing mostly ICAM1+
and a few DPP4+ cells.
Based on these data, we conclude that the progenitor cells in human subcutaneous
adipose tissue are organized into two subtypes: DPP4+ interstitial progenitors and
ICAM1+ committed preadipocytes. These conclusions are based on similar patterns of in
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vitro functionality and gene expression between the groups identified in humans and
those seen in mice. Future work should employ transplantation studies to determine
whether, as in mice, human DPP4+ cells are capable of generating ICAM1+ cells and
adipocytes in vivo. Additional studies should also extend these findings to determine
whether other human adipose tissue depots, including the visceral WAT and
supraclavicular BAT, are similarly organized. Overall, this work strongly suggests that
the progenitor cells in human and mouse adipose tissue are organized into comparable
lineage schemas and lays the groundwork for future studies exploring the function and
dysfunction of adipocyte progenitors during metabolic disease.
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Chapter 5: Discussion and Future Directions
Portions of the text of this chapter are adapated from : Merrick, David., Sakers,
Alexander., Irgebay, Zhazira., Okada, Chihiro., Calvert, Catherine., Morley, Michael P., Percec,
Ivona., Seale, Patrick. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue.
Science (80-. ). 364, eaav2501 (2019).(Merrick et al., 2019)
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5.1

Summary
The work presented here aimed to address several outstanding questions in the

field of adipose tissue biology. First, we sought to determine the biologically meaningful
subdivisions of adipocyte progenitor cells present within adipose tissue. In Chapter 2, we
employed single cell RNA sequencing of subcutaneous adipose tissue from developing
and adult mice and found three major populations of progenitor cells: Dipeptidyl
peptidase–4–expressing (DPP4) Interstitial Progenitors, Intercellular adhesion molecule–
1–expressing (ICAM1) committed preadipocytes, and CD142+/Clec11a+ “group 3”
cells. Computational cell trajectory analyses identified these cell types as components of
a mesenchymal lineage hierarchy active in adipose tissue.
DPP4+ cells are highly proliferative and multipotent progenitors that are
relatively resistant to differentiation into adipocytes. ICAM1+ cells are committed
preadipocytes that express Pparg and are poised to differentiate into mature adipocytes
with minimal stimulation. CD142+/Clec11a+ cells represent a distinct adipogenic
population in murine subcutaneous adipose that share many properties with ICAM1+
preadipocytes. In vivo cell transplantation studies confirmed our in silico lineage
predictions and showed that DPP4+ progenitors give rise to both ICAM1+ and CD142+
preadipocytes before eventual differentiation into mature adipocytes.
DPP4+ cells depend on transforming growth factor–β (TGFβ) signaling to
maintain their progenitor identity, whereas ICAM1+ preadipocytes are refractory to the
proliferative and anti-adipogenic actions of the TGFβ pathway. Histological examination
of murine subcutaneous adipose tissue showed that ICAM1+ preadipocytes are
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intercalated between mature adipocytes, potentially occupying a perivascular niche. The
DPP4+ progenitor cells are located in an anatomically distinct niche surrounding the
adipose depot, which we term the reticular interstitium.
Second, we examined how these progenitor cells respond to common adipogenic
stimuli such as diet induced obesity. In Chapter 3, we showed that acute onset of diet
induced obesity in mice led to a depletion of DPP4+ mesenchymal progenitors and a
reduction in the adipogenic differentiation competency of preadipocytes, specifically in
visceral white adipose tissue.
Third, we examined whether we could identify a preadipocyte committed to the
thermogenic beige adipocyte lineage rather than to the white adipocyte lineage. We
employed a novel model of cold naïve (thermoneutral) mice to ensure that we were
capturing mice who had never had a stimulus for beige adipogenesis. Unbiased single cell
RNA sequencing of whole SVF failed to find any new stromal cell populations induced
by 1 day of cold exposure. Deep sequencing of DPP4+, ICAM1+, and CD142+ cells
from thermoneutral and 1 day cold exposed mice revealed that cold exposure upregulated
a common set of genes in all groups corresponding to a general signature of adipogenesis.
We did not find evidence for the existence of a committed beige preadipocyte but note
that the duration of cold exposure may have been too short.
Finally, in Chapter 4, we extended these results by examining human tissue.
Single cell analysis of human subcutaneous adipose tissue revealed distinct DPP4+ and
ICAM1+ populations but failed to find evidence of a distinct CD142+ population. The
DPP4+ and ICAM1+ populations in human tissue displayed functional similarities to
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their analogous mouse counterparts in vitro. Specifically, human DPP4+ progenitors have
high proliferative potential, are relatively resistant to adipocyte differentiation, and are
sensitive to the effects of TGFβ signaling. In contrast, human ICAM1+ cells are highly
adipogenic and are resistant to the anti-adipogenic effects of TGFβ.

5.2

Comparison of Our Cellular Populations to Previous Literature

Comparison of our results to recent scRNA-Seq based publications
Burl et al. performed single cell RNAseq on SVC from adult mouse iWAT and
eWAT and identified populations similar to those we found in 12-day old pups (Burl et
al., 2018). Specifically: the group-defining genes for ASC2 (DPP4+/Pi16+) overlap
extensively with genes expressed in our Group 1 (DPP4+) population, and ASC1
(ICAM1+/Col4a2+) is similar to our Group 2 (ICAM1+) cells (Figure 2.21).
Notably, Burl et al. did not describe a third group that is equivalent to our
CD142+/Clec11a cells. We speculate that this discrepancy is due to two features of their
analysis. First, they did not regress cell cycle genes when performing their clustering.
Second, when analyzing the same tissue, they chose to employ fewer clusters than we did
(7 vs 10). When analyzing our single cell data with fewer clusters, we find that the Group
2 (ICAM1+) and Group 3 (CD142+) cells combine into a single group, which Burl et al.
identified as ASC1.
Hepler et al. defined two main subtypes of Pdgfrb expressing (mural) cells in murine
eWAT: fibro-inflammatory precursors (FIPs) that express many overlapping markers
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with our Group 1 DPP4+ cells; and adipocyte precursor cells (APCs) that are similar to
our Group 2 ICAM1+ cells (Figure 2.22) (Hepler et al., 2018). Interestingly, FIPs from
visceral adipose have low adipogenic differentiation capacity. However, the authors
noted that their FACS strategy used to isolate FIPs from eWAT (PDGFRβ+, LY6a+,
CD9+) did not identify an analogous population in subcutaneous adipose. Indeed, the
three markers used to purify FIPs are not specifically enriched in Group 1 DPP4+ cells
(Figure 2.22, top three genes), though many other FIP-defining markers are highly
concordant between the populations. Therefore, FIPs may represent a subset of DPP4+
cells that are uniquely present in the visceral eWAT depot.
Schwalie et al. identified three cell clusters that largely coincide with the groups that
we studied (Figure 2.23) (Schwalie et al., 2018). Schwalie population 1 (P1) expresses a
similar gene signature as our Group 1 (DPP4+) cells; P2 corresponds to our Group 2
(ICAM1+) cells; and P3 corresponds to our Group 3 (CD142+/Clec11a+) cells. However,
a notable discrepancy concerns the functional properties of CD142+ Group 3/P3 cells.
Schwalie et al. show that mouse and human P3 (CD142)+ cells, which they named
Adipogenesis-regulatory (Areg) cells, have low adipogenic potential and are also capable
of inhibiting the differentiation of preadipocytes. In contrast, our study indicates that
these cells are highly adipogenic both in vitro and upon transplantation in vivo. This
divergence likely stems from key differences in our respective FACS strategies for cell
purification. For many of their mouse studies, Schwalie et al. used ABCG1 in addition to
CD142 to enrich for the P3 population. Examination of the expression pattern of Abcg1
in our single cell data shows almost no mRNA detectable in Groups 1-3 (Figure 2.23).
144

We performed extensive validation of our flow sorting strategy by bulk RNAseq analyses
and showed that the CD142+ cells we isolated were highly enriched for expression of the
corresponding group 3-defining genes (Figure 2.7). Taken together, these results
demonstrate that Group 3 cells are an adipogenic population, related to ICAM1+ group 2
cells, in the adipose lineage. We speculate that the anti-adipogenic activity attributed to
P3 CD142+ cells by Schwalie et al. resides in a different cell type captured in their flow
sorting strategy.
Comparison to the broader literature
At the outset of this project, we aimed to find the most biologically meaningful
subdivisions of adipocyte progenitor cells present in the stromal vascular fraction of
adipose tissue. To do so, we avoided introducing bias by 1) analyzing the whole SVF via
scRNA-seq rather than a subset of cells as is common in other reports (Burl et al., 2018;
Hepler et al., 2018), 2) performing unbiased clustering to identify transcriptionally
distinct progenitor cell populations, and 3) developing FACS sorting strategies to isolate
clusters identified on scRNA-seq with high fidelity. Importantly, we did this without
attempting to fit our observed data to previous reports in the literature. We therefore
believe that our strategy for categorizing adipocyte progenitors captures the most
biologically relevant subdivisions.
In Chapters 2 and 4, we identified three populations of adipocyte progenitors in
mice (DPP4+, ICAM1+, and CD142+ cells) and two in humans (DPP4+ and ICAM1+).
Consistent with the model proposed in Figure 1.3 we find evidence for a division of the
progenitor cell compartment of adipose tissue into two major types: A) cells that are more
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committed to the adipocyte lineage (ICAM1+ and CD142+ cells in mice, ICAM1+ cells
in humans) and B) precursors to committed preadipocytes, which have more multilineage
potential (DPP4+ cells in both humans and mice).
A brief comparison to the literature suggests that DPP4+ cells are roughly
analogous

to

the

following

two

populations

in

previous

reports:

Lin-

:CD29+:CD34+:Sca1+:CD24+ cells (Rodeheffer, 2008) and CD34high:CD38- cells
(Carrière et al., 2017). ICAM1+ and CD142+ cells are roughly analogous to the
following populations reported in the literature: CD34Low:CD38+ cells (Carrière et al.,
2017), PDGFRβ+/Pparg+ cells (W. Tang et al., 2008; Vishvanath et al., 2016), Pref1+
cells (Hudak et al., 2014a). The less selective markers PDGFRα and PDGFRβ were
broadly expressed on all three cell groups, consistent with their roles as general
mesenchymal markers (Figure 2.1-2.4). The following sections will explore these
comparisons in more detail.
Comparison to Lin-:CD29+:CD34+:Sca1+:CD24+ cells
Our classification of adipocyte progenitor cells into two major functional groups
is conceptually similar to work done by the Rodeheffer lab (R. Berry & Rodeheffer,
2013; Jeffery et al., 2015, 2016; Rodeheffer, 2008). Their work divides the SVF into two
populations: Lin-:CD29+:CD34+:Sca1+:CD24+ (hereafter CD24+ cells) and Lin:CD29+:CD34+:Sca1+:CD24- (hereafter CD24- cells). CD24+ cells are reported to be
the progenitors to CD24- cells which subsequently make adipocytes (R. Berry &
Rodeheffer, 2013). Our single cell and functional studies largely agree with this body of
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work but suggest that CD24 does not optimally subdivide the various adipogenic cell
populations.
Our single cell data reveal that Cd29, Cd34, and Sca1 are expressed among all
Lin- cells (on Dpp4+, Icam1+ and, Cd142+ cells) and thus serve as general mesenchymal
markers (Figures 2.1-2.4). It is therefore likely that our respective FACS strategies are
yielding similar groups of cells. Importantly, our single cell data reveal that Cd24 is
expressed in a small subset of Dpp4+ cells and that all Icam1+ and Cd142+ cells are
Cd24 negative (Figures 2.1-2.4).
While CD24 enriches for DPP4+ cells, we speculate that it is inferior as a marker
for two reasons. First, analysis of our single cell data suggests that the CD24 negative
group isolated by the Rodeheffer lab is a heterogenous mixture containing DPP4+,
ICAM1+, and CD142+ cells. Our work clearly shows that these three populations have
distinct functional properties and should be considered separately.
Second, CD24 is likely unnecessarily restrictive as a marker, as our single cell
data suggest that it is only expressed on a subset of DPP4+ cells. Notably, the Cd24+
cells do not cluster as a distinct group. Dropout of less highly expressed transcripts may
explain this pattern. Nonetheless, DPP4+ appears to mark a similar set of cells with more
specificity and is therefore a better marker.
Functional studies indicate that DPP4+ cells behave analogously to CD24+ cells;
both populations have enhanced proliferative and multilineage potential and can produce
committed preadipocytes (ICAM1+ and CD142+, or CD24-) cells after transplantation in
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vivo. Notably, histology showing the anatomic location of CD24+ cells has never been
reported in the literature. Overall, our analysis indicates that DPP4 is a more appropriate
marker than CD24 for subdividing the progenitor pool.
Comparison to CD34Low:CD38+ versus CD34High:CD38A single report has described CD34Low:CD38+ cells as having similar gene
expression patterns and in vitro adipogenic potential as our ICAM1+ cells (Carrière et al.,
2017). This classification strategy is conceptually similar to the CD24 based strategy
above and suffers from the same limitations. Specifically, CD38 is only expressed on a
subset of ICAM1+ and CD142+ cells and this strategy fails to distinguish between
ICAM1+ and CD142+ cells.
Comparison to Pref1 cells
In developing (p12) mice, our single cell transcriptomic data reveal that there is
nearly complete overlap between cells expressing Pref1 and cells that are
Icam1+/Cd142- (Figure 2.1). This allowed us to use PREF1 as a histological marker for
ICAM1+ cells (Figures 2.16 and 2.17). Based on these data, we conclude that FACS
isolated PREF1+ and ICAM1+ cells are likely equivalent populations. Characterization
of PREF1+ cells during the course of embryonic adipogenesis and early post-natal has
been reported in the literature and is probably applicable to ICAM1+ cells (Gulyaeva,
Nguyen, Sambeat, Heydari, & Sul, 2018; Hudak et al., 2014b).
Notably, Pref1 expression is not observed in the adult mouse or human single cell
data, suggesting a developmentally restricted pattern of gene expression. PREF1 has a
well-studied role in inhibiting adipogenesis (Hudak & Sul, 2013). The lack of detectable
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Pref1 expression in adult ICAM1+ cells suggests that these adult cells may have
important differences from their counterparts in pups. Thus, future experiments should
examine how adipocyte progenitor cells change from the early post-natal period to
adulthood.
Comparison to PDGFRα+ and PDGFRβ+ cells
Both Pdgfra and Pdgfrb were broadly expressed among Dpp4, Icam1, and Cd142
expressing cells in our single cell studies performed in mice and humans (Figures 2.1-2.4,
4.5). Pdgfrb showed slight enrichment on Icam1 and Cd142 expressing cells, consistent
with reports describing PDGFRβ/Pparg+ cells in the literature (Figures 2.1-2.4). Overall,
neither Pdgfrb nor Pdgfra emerged as a selective marker of a transcriptionally distinct
population of cells. There are well described differences between PDGFRα+ and
PDGFRβ+ cells in the literature, including different anatomic localizations and levels of
contribution to cold and high fat diet induced adipogenesis (Y. Lee et al., 2012;
Vishvanath et al., 2016). Therefore, future work should examine if expression of
PDGFRα+ or PDGFRβ+ can be used to further subclassify DPP4+, ICAM1+, and
CD142+ cells.

5.3

Adipogenesis In Vivo
Our transplantation studies show that all cellular populations have the capacity to

make adipocytes in vivo (Figure 2.13). They also demonstrate that DPP4+, ICAM1+, and
CD142+ cells are constituents of a lineage hierarchy. Specifically, DPP4+ cells have the
capacity to generate both ICAM1+ and CD142+ cells; ICAM1+ and CD142+ cells can
interconvert, but neither population generates appreciable numbers of DPP4+ cells after
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transplantation. We have high confidence in our transplantation studies, as we detected
integration of the transplanted cells into the architecture of the native tissue (Figure 2.13).
While these transplantation studies were high quality and informative, they have several
limitations and numerous questions remain.
Lineage tracing models: which cells contribute and which are required
First, transplantation studies show the capacity for transplanted cells to
differentiate in vivo, but they do not prove that the endogenous population of cells
behaves similarly in their native context. The gold standard for answering such a question
is lineage tracing (Kretzschmar & Watt, 2012). Our lab is currently generating a
Dpp4CreERT2/+ Rosa26mTmG mouse model which will be used to lineage trace DPP4+
interstitial progenitors during normal development and under adipogenic conditions such
as cold exposure and diet induced obesity. This genetic model will prove whether DPP4+
cells do indeed make ICAM1+ cells, CD142+ cells, and adipocytes in vivo.
Second, the immediate precursor to adipocytes remains unknown. Specifically,
ICAM1+ and CD142+ cells each generated both adipocytes and the reciprocal cellular
population upon transplantation (Figures 2.13-2.14). It is unclear whether CD142+ cells
generate adipocytes directly or by first transitioning into an ICAM1+ cell. Similarly, it is
unknown whether ICAM1+ cells can generate adipocytes directly, or if they must first
transition into CD142+ cells. A third possibility is that both ICAM1+ and CD142+ cells
can generate adipocytes directly.
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Our data suggest that the ICAM1+ population is the most likely immediate
precursor to adipocytes. Single cell transcriptomic data indicate that ICAM1+ cells have
the highest expression of key adipocyte identity genes such as Pparg and Fabp4.
Furthermore, ICAM1+ cells have the highest adipogenic capacity in vivo and are resistant
to anti adipogenic signaling via TGFβ. Lastly, an equivalent population of ICAM1+ cells
but not CD142+ cells is present in humans, suggesting that, at least in humans, the
immediate precursors to adipocytes are ICAM1+ cells.
The question of whether ICAM1+ or CD142+ cells are the immediate precursors
to adipocytes cannot be answered with current lineage tracing technology, since the two
cell types can readily interconvert. A more tractable question is to ask the relative
contribution of ICAM1+ and CD142+ cells to the adipocyte lineage using lineage tracing
models. We are currently in the process of generating a reporter mouse for CD142+ cells
based on their high expression of Clec11a (Clec11aCreERT2 Rosa26mTmG). Furthermore, we
are working to determine a suitable Cre driver specific to ICAM1+ cells in vivo.
Published work using a Pref1 (Pref1rtTA-TRE-Cre) suggests that it may be a useful marker
for ICAM1+ cells during embryogenesis and early development, but not during
adulthood (Gulyaeva et al., 2018; Hudak et al., 2014b). Thus, the search for a specific
Cre driver for ICAM1+ cells is ongoing.
Third, what are the required cell types for adipogenesis in vivo during postnatal
development and during adulthood? Throughout our work, we largely considered
adipocyte progenitor cells to be equivalently organized in mice from a wide range of ages
(from as young as p12 in the transplantation studies to as old as 16 weeks in the diet
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induced obesity studies). This assumption was made based on scRNA-Seq and flow
cytometry data showing similar populations of DPP4+, ICAM1+, and CD142+ cells
across multiple ages. Some evidence in the literature suggests that adipogenesis from p0p30 is dependent upon different pools of precursors than from p30 onward (Hudak et al.,
2014a; Jiang et al., 2014). One report showed that genetic deletion of Pparg in Pparg
expressing cells (PpargtTA-TRE-Cre/fl) at E10.5 leads to a late onset lipodystrophy but
normal adipose tissue at birth. Such a result suggests that the cells responsible for adult
adipogenesis are 1) specified at E10.5 and 2) express high enough levels of Pparg to
induce deletion. Our work suggests that DPP4+ cells, which do not express Pparg, are
responsible for maintaining the adult adipose tissue. To resolve this apparent
inconsistency, we should test the requirement for DPP4+, ICAM1+, and CD142+ cells in
adipogenesis at different developmental stages.
These experiments can be performed in genetic lineage tracing models in which
Pparg is deleted under the control of an inducible cell type specific Cre (ex. Dpp4CreERT2
Ppargfl/fl Rosa26mTmG). Deletion of Pparg will prevent adipogenesis in the affected
population (Cristancho & Lazar, 2011). The lineage tracing construct will allow us to
track the fate of the affected cells. We hypothesize that DPP4+ cells are required for
adipogenesis during the immediate post-natal period based upon our transplantation
studies and histology showing many DPP4+/ICAM1+ double positive cells at the leading
edge of developing inguinal WAT in p0.5 and p2 mice (Figures 2.16 and 2.17). Deletion
of Pparg early in development in DPP4+ cells should therefore lead to a profound
lipodystrophy. It is unclear however whether DPP4+ cells are required for adipogenesis
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once the mouse has reached adulthood. Therefore, these experiments will be essential for
rigorously proving the necessary components of the adipocyte progenitor cell lineage
hierarchy identified here in vivo.
Model of adipogenesis: vascular invasion into the reticular interstitium
The model of adipogenesis presented in this thesis conflicts with the prevailing
model regarding the location of adipocyte progenitors (Figures 1.2, 2.15, 2.20). We
suggest here that adipocyte progenitors reside in the reticular interstitium (RI), a layer of
tissue that surrounds and courses through the adipose tissue in the form of fibrous bands
(Figure 2.20). The predominant model posits that adipocyte progenitors reside in a
perivascular location (R. Berry et al., 2013; W. Tang et al., 2008). In contrast, our work
shows that DPP4+ cells are seemingly excluded from the perivascular niche (Figure
2.19).
How can these two models be reconciled? First, we suggest that most of the
adipocyte progenitors identified in the literature to date are equivalent to the ICAM1+
population rather than to the DPP4+ population (see the section above on comparisons to
the literature). Therefore, DPP4+ cells represent an upstream population to the one
occupying the perivascular niche.
Second, we posit that angiogenesis into the RI is a key initiating event in the
progression of DPP4+ cells into ICAM1+ committed preadipocytes. Under this model, as
blood vessels grow into the RI, DPP4+ cells respond to signals from the perivascular
niche and mature into ICAM1+ cells, which now occupy the perivascular space.
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Furthermore, this model would be consistent with the recognized importance of
angiogenesis in the hyperplastic growth of adipose tissue (Corvera & Gealekman, 2014;
Hong et al., 2015). One test of this vascular invasion model would be to examine the
effects of angiogenic recruitment into the RI by knocking out or overexpressing Vegf
under the control of a DPP4+ cell specific Cre driver.
What signals restrain and promote adipogenesis in vivo?
A major effort in the field is to determine the signals that promote and restrain
adipogenesis in vivo. Adipogenesis is generally divided into two stages: commitment and
terminal differentiation (Cristancho & Lazar, 2011). Historically, it has been difficult to
study the process of commitment due to a lack of markers for discerning which cells are
committed to the adipocyte lineage and which are not. Our work aides in this effort by
defining the in vivo identities of uncommitted cells in the adipocyte lineage (DPP4+) and
of committed cells (ICAM1+). Using these markers, it is possible to disentangle
questions about adipocyte commitment (which should be performed on DPP4+ cells)
from questions about induction of differentiation (which should be performed on
ICAM1+ cells).
Numerous signals have been reported to inhibit adipogenesis, including WNTs,
TGFβ, and hedgehog signaling (Cawthorn et al., 2012; Ignotz & Massagut, 1985; Suh et
al., 2006). Many of these signals are reported to inhibit adipocyte terminal differentiation.
In Chapter 2, we suggest a role for TGFβ signaling in regulating adipogenic commitment
by modulating the position of adipocyte progenitor cells along the DPP4+ cell to
ICAM1+ cell lineage trajectory (Figures 2.12). Notably, ICAM1+ cells were still able to
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undergo efficient adipogenesis even in the presence of TGFβ signaling. We therefore
conclude that TGFβ inhibits adipogenesis not by restraining committed preadipocytes but
by promoting the maintenance of DPP4+ cell identity and preventing lineage progression.
Future studies should examine the role of TGFβ signaling on DPP4+ cells in vivo
and specifically test its requirement for the maintenance of in vivo DPP4+ cell identity.
Two genetic models with lineage tracing reporters will be necessary for these
experiments: 1) Overexpression of TGFβ in DPP4+ cells (Dpp4CreERT2 Lox-Stop-Lox Tgfb
mTmG

) and 2) knockout of one or more of the TGFβ receptors in DPP4 cells

Rosa26

(Dpp4CreERT2 Tgfbr1fl/fl Tgfbr2fl/fl Rosa26

mTmG

). We hypothesize that acute knockout of

TGFβ signaling will promote rapid lineage progression into ICAM1+ cells and into
adipocytes while overexpression will have the opposite effect.
Finally, the work presented here provides a paradigm for studying factors which
affect lineage commitment in vitro. Future work should use similar techniques to those
employed in Chapter 2 to examine how factors like WNTs, BMPs, ECM stiffness, and
Hedgehog signaling affect the identity maintenance and lineage progression of DPP4+
cells.

5.4

The Role of DPP4 and DPP4+ Cells in Adipose and Other Tissues
DPP4 is an amino peptidase which cleaves a dipeptide off of the N-terminus of its

targets (Deacon, 2019). DPP4 exists in two forms: as an integral membrane protein and in
a soluble form (generated by proteolytic cleavage) that circulates in the plasma and is
present in extracellular fluid. DPP4 is produced by a wide variety of tissues including the
intestinal brush border, vascular endothelium, liver, pancreas, and numerous immune
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cells (Deacon, 2019). DPP4 has many substrates but has been most widely studied for its
role in inactivating the incretin hormone glucagon like peptide 1 (GLP1). DPP4 also has
many functions that are not dependent on its proteolytic activity, including interacting
with components of the ECM and acting as a ligand or receptor for numerous molecules
(Klemann & Wagner, 2016). Given the broad expression pattern and manifold roles of
DPP4, it is useful as a cell type specific marker only when used in combination with
other markers or phenotypic characteristics. In this work, we report that DPP4+ cells
within the adipose tissue are an anatomically and functionally distinct subset of adipocyte
progenitors. Numerous questions about these cells remain, including: 1) how the DPP4+
cells identified here relate to fibroblast populations in other tissues, and 2) the function of
DPP4 in these cells.
Several groups have reported the presence of similar populations of DPP4+
fibroblasts in other tissues, most notably in the skin and breast tissue (Borrelli et al.,
2019; Rinkevich et al., 2015; Soare et al., 2019). In both the skin and breast, DPP4+ cells
are reported to be enriched in the setting of tissue fibrosis (systemic sclerosis and keloids
in the skin, radiation induced fibrosis in the breasts) (Borrelli et al., 2019; Soare et al.,
2019; Xin et al., 2017). We have shown that DPP4+ cells reside within a niche composed
of fibrous tissue, which we termed the reticular interstitium (Figure 2.16). We speculate
that DPP4+ cells are active in generating and maintaining this ECM; in the pathological
setting, DPP4+ cells may be responsible for adipose tissue fibrosis. Given the description
of pro-fibrotic DPP4+ cells in the skin and breast, future work should examine whether
excessive numbers or activity of DPP4+ fibroblasts is a general feature of tissue fibrosis
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throughout the body. The related question of how DPP4+ fibroblasts in different tissues
compare to those in adipose, during normal physiology and fibrotic disease, should also
be explored.
Consistent with a role for DPP4+ fibroblasts cells in driving tissue fibrosis,
several studies have shown that DPP4 inhibitors can reduce hypertrophic scarring in skin
wounds (Leavitt et al., 2016; M. Long et al., 2018; Mah et al., 2017; Schu et al., 2012).
Furthermore, DPP4 inhibition has been shown to reduce skin fibrosis and proliferation of
DPP4+ fibroblasts in a murine model of systemic sclerosis (Soare et al., 2019). However,
the mechanism by which DPP4 inhibition is mediating these effects is unknown. We
speculate that DPP4 is playing a functional role in the DPP4+ interstitial progenitor cells
found in adipose tissue. Therefore, further studies should be done to examine 1) the role
of DPP4 in DPP4+ interstitial progenitors and 2) whether DPP4 inhibition can reduce age
and obesity induced adipose tissue fibrosis (Divoux et al., 2010a).

5.5

Progenitor Cell Responses to Obesity and Cold Exposure

DPP4+, ICAM1+, and CD142+ cells are found in all major adipose tissue depots
In Chapter 3, we identified analogous groups of DPP4+, ICAM1+, and CD142+
cells with similar functional properties in visceral, subcutaneous, and brown fat. We
therefore speculate that the lineage hierarchy identified in Chapter 2, in which DPP4+
cells are the common progenitor to ICAM1+ and CD142+ cells, is also present within
these tissues. Future work should include lineage tracing studies, as described above, in
all adipose tissue depots to test this possibility.
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Depot specific responses of progenitor cells to diet induced obesity
We asked how DPP4+, ICAM1+, and CD142+ cells behave under diet induced
stress. The most striking finding from these studies was a depletion of DPP4+ cells in the
visceral adipose tissue induced by high fat diet. A secondary finding was the profound
loss of proliferative and adipogenic function in all subsets of progenitor cells of the
visceral depot. Notably, the subcutaneous inguinal adipose tissue was seemingly
protected from these effects. These results are consistent with work by other groups
showing depot specific responses and a reduction in total adipocyte progenitor number in
the visceral adipose upon high fat feeding (Jeffery et al., 2015; Macotela et al., 2012; Q.
A. Wang et al., 2013). Our work adds nuance to these results by showing that HFD
induces a specific depletion of DPP4+ interstitial progenitors. Overall, these findings
suggest that progenitor cell exhaustion and reduced precursor differentiation may
contribute to the failure of hyperplastic expansion and to the pathological remodeling of
visceral WAT in obesity.
We hypothesize that obesity may induce cell autonomous changes in progenitor
cell function, perhaps due to the damaging effects of an inflammatory microenvironment
specific to the visceral adipose tissue (Quail & Dannenberg, 2019). Alternatively, the
high adipogenesis environment of the visceral adipose tissue may account for the
observed results (Figure 3.7). In the visceral compartment, where there is high
adipogenesis during diet induced obesity, only the least adipogenic progenitors remain
after prolonged caloric excess (Q. A. Wang et al., 2013). In contrast, in the inguinal
WAT, where there is low adipogenesis during diet induced obesity, such a selection
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process does not occur, and we see maintenance of the functional capacity of the tissue
resident progenitors.
Future work should focus on the mechanism by which the visceral progenitor
pool becomes exhausted and less adipogenic in obesity. It should also examine the time
course of these changes in progenitor cells, as human obesity is not characterized by a
loss of adipocyte progenitors (Jules Hirsch & Batchelor, 1976). It is possible that acute
episodes of weight gain induce progenitor cell exhaustion, followed by eventual rebound.
Responses of progenitor cells to cold exposure
We hypothesized that a short episode of cold exposure in cold naïve mice would
reveal a new population of differentiating or committed beige preadipocytes. We failed to
find evidence for such a cell type but conclude that our analysis is probably limited by an
inadequate duration of cold exposure.
To attempt to identify committed beige preadipocytes, we designed our
experimental paradigm with two considerations in mind. First, the mice were housed at
thermoneutrality from birth and therefore should have never received signals to undergo
beige adipogenesis. This scheme should serve to limit the amount of re-activation of
“whitenened” beige adipocytes that has been reported in the literature (Roh et al., 2018;
Rosenwald et al., 2013). Second, few new adipocytes form within one day of cold
exposure; therefore, we anticipated that many of the cold induced changes should occur
in the precursor compartment, before the cells have the time to become mature adipocytes
(Q. A. Wang et al., 2013). Unfortunately, single cell analysis identified no novel groups
of cells that were present in cold exposed mice but not in thermoneutral mice.
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Similarly, our analysis of the bulk transcriptomes of sorted DPP4+, ICAM1+, and
CD142+ cells from cold naïve and 1 day cold exposed mice failed to clearly identify
which precursor subset, if any, is fated to become beige adipocytes. These experiments
were characterized by relatively modest gene expression changes and no clear pattern of
thermogenic gene expression (Figures 3.9 and 3.15). The one discernable trend was that
cold exposure upregulated genes associated with adipocyte differentiation and identity
(Figure 3.14).
Combined, these analyses are consistent with the hypothesis that all progenitor
cells in the inguinal white adipose tissue have the capacity to generate beige adipocytes.
However, due to the short duration of cold exposure, it is likely that our analyses were
performed too early in the process of cold-induced tissue remodeling. Therefore, future
work should first determine the appropriate timeline for observing such changes.
Subsequent experiments can then more adequately test the nature of the cold response in
adipocyte progenitor cells.

Adipogenesis assays: commentary on best practices
Throughout the course of this work, we relied heavily on the use of in vitro
adipogenesis assays and image-based quantification techniques to discern the relative
adipogenic potential of DPP4+, ICAM1+, and CD142+ cells isolated from mice and
humans. While adipogenesis assays are employed broadly, there is considerable
variability in how they are executed. Therefore, below is a discussion of best practices.
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The most common incorrect variant is to plate different cellular populations at
low density and grow them to confluence for several days before initiating adipogenic
differentiation. This method is often employed due to the low yield of adipocyte
progenitor cells, especially when using FACS to isolate distinct populations. Importantly,
this method does not directly assay adipogenic potential but rather measures the ability to
undergo adipogenesis, after many rounds of cell divison. A second common error is to
quantify the total amount of lipid without accounting for total cell number. Wells with
more cells can have much lower per-cell rates of adipogenesis but similar overall lipid
accumulation. The conflation of in vitro adipogenic and proliferative potential may be
responsible for seemingly inconsistent reports in the literature and future work should be
careful to avoid this pitfall.

5.6

Conclusion
Overall, these studies define a developmental hierarchy of adipose progenitors

consisting of DPP4+ interstitial progenitors that give rise to committed ICAM1+ and
CD142+ preadipocytes, which are poised to differentiate into mature adipocytes. The
careful dissection of the lineage relationships between adipocyte progenitor cells
presented here represents an important advance in our understanding of adipose tissue
biology. We speculate that targeting one or more of these cell populations may be
beneficial for promoting adaptive hyperplastic adipose growth to ameliorate metabolic
disease. A key finding from this work is that adipose progenitor cells reside in the
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reticular interstitium, a recently appreciated network of collagen and elastin fibers that
encases many organs, including adipose depots. Our results raise the possibility that
DPP4+ cells, in addition to serving as progenitor cells for adipocytes in fat depots, may
play important roles in the functioning of other tissues.

162

Materials and Methods
Human Adipose Tissue Samples
All human adipose tissue samples were obtained from living donors undergoing cosmetic
surgery. Tissue samples consisted of 1-10 kg intact blocks of discarded tissue, including
skin and subcutaneous adipose, from procedures to remove excess skin and adipose tissue
from the abdomen and flanks. Collection of tissue and processing was initiated within 1-3
hours of removal from the patient. This work was performed under the approval of IRB
#812150 and IRB #824825. Human subject demographics are outlined in Fig. S22.
Isolation of Stromal Vascular Cells from Human Subcutaneous Adipose
The skin and cauterized edges of human tissue samples were removed to yield an intact
block of subcutaneous fat which was unmanipulated by the surgical procedure. 300-500g
of tissue was manually minced and digested with Collagenase D (0.75 unit/mL; Roche)
and Dispase II (1.2 units/ml Roche) in DMEM/F12 containing 0.4% fatty acid free
bovine serum albumin (Sigma) at 37˚C with agitation for 45 min and shaking for 10 sec
at 15 min intervals. Digestion was performed at a ratio of 1g of tissue to 1mL of digestion
medium. The digestion was quenched with DMEM containing 10% FBS and the
dissociated cells were filtered twice through a single layer of gauze to remove large
undigested particles followed by centrifugation at 400 x g for 5 minutes at RT. The
resulting supernatant containing mature adipocytes was aspirated and the pellet,
consisting of stromal vascular cells, was resuspended and passed through a 100uM filter
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followed by centrifugation at 400 x g for 5 minutes at RT. Cells were re-suspended in red
blood cell lysis buffer (Biolegend) for 5 minutes at room temperature then quenched in
DMEM containing 10% FBS. Cells were then passed through a 40 μM filter and
collected by centrifugation at 400 x g for 5 minutes. Cells were recovered in FACS buffer
(HBSS containing 3% FBS, Fisher) and kept on ice for the duration of processing.
Animals
C57BL/6J WT (Stock #000664), and C57BL/6J:ROSAmT/mG (Stock #007676) mouse
lines were obtained from Jackson Laboratories. CD1 WT (Stock #022) were obtained
from Charles River. 129SVE (Stock #129S6/SvEvTac) mice were obtained from
Taconic. Diet-induced obese C57BL/6J mice (Stock #380050) and control animals (Stock
#380056) were obtained from Jackson Laboratories and maintained on their respective
diets until harvest. All animal procedures were performed under the guidance of the
University of Pennsylvania Institutional Animal Care and Use Committee.
Isolation of Stromal Vascular Cells from Mouse Adipose
Inguinal and axillary subcutaneous white adipose depots were surgically removed from
wild type mice and processed for stromal vascular cell enrichment. Briefly, adipose
tissues were manually minced and digested with Collagenase D (1.5 unit/mL; Roche) and
Dispase II (2.4 units/ml Roche) in DMEM/F12 containing 0.8% fatty acid free bovine
serum albumin (Sigma) at 37˚C with agitation for 45 min and vortexing for 10 sec at 15
min intervals. The digestion was quenched with DMEM/F12 containing 10% FBS and
the dissociated cells were passed through a 100 μM filter, followed by centrifugation at
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400 x g for 5 minutes. The resulting supernatant containing mature adipocytes was
aspirated and the pellet, consisting of stromal vascular cells, was re-suspended in red
blood cell lysis buffer (Biolegend) for 5 minutes at room temperature then quenched in
DMEM/F12 containing 10% FBS. Cells were then passed through a 40 μM filter and
collected by centrifugation at 400 x g for 5 minutes. Cells were recovered in FACS buffer
(HBSS containing 3% FBS, Fisher).
Fluorescence-Activated Cell Sorting (FACS)
Mouse: Stromal vascular cells from the subcutaneous adipose of ~20-30 mice (age p10p20) or 10-20 mice (age 8 weeks or older) were pooled and re-suspended in FACS buffer
for incubation with the following antibodies for 30min at 4˚C: CD26(DPP4)-FITC
(Biolegend, San Diego, CA, cat#137806 1:200); anti-mouse ICAM1-PE/Cy7 (Biolegend
cat#116122 1:100), anti-mouse CD45-APC/Cy7 (Biolegend; cat#103116 1:1000), antimouse CD31-APC-Fire (Biolegend cat#102528 1:1000), anti-mouse CD142 1:100 (Sino
Biological cat#50413-R001), pre-conjugated with Biotium Mix-n-Stain CF647 (Sigma
cat#MX647S100). DAPI (Roche cat#10236276001 1:10000) was added for the final 5
minutes. The cells were washed three times with FACS buffer to remove unbound
antibodies. The cells were sorted using a BD FACS Aria cell sorter (BD Biosciences)
equipped with a 100 micron nozzle and the following lasers-filters: DAPI: 405-450/50;
FITC: 488-515/20; mTomato: 532-610/20; PE/Cy7: 532-780/60; CF647: 640-660/20;
APC/Cy7 and APC-Fire 640-780/60. All compensation was performed at the time of
acquisition in Diva software using compensation beads (BioLegend cat# A10497) for
single color staining and SVCs for negative staining and fluorescence (DAPI, mTomato).
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Human: Stromal vascular cells were re-suspended in FACS buffer for incubation with the
following antibodies for 60min at 4˚C: CD26(DPP4)-FITC (Biolegend, San Diego, CA,
cat# 302704 1:100); anti-mouse ICAM1-PE/Cy7 (Biolegend cat# 353116 1:100), antimouse CD45-APC/Cy7 (Biolegend; cat# 368516 1:100), anti-mouse CD31-APC/Cy7
(Biolegend cat#303120 1:100), anti-mouse CD142-APC (Biolegend cat# 365206 1:100).
DAPI (Roche cat#10236276001 1:10000) was added for the final 5 minutes. The cells
were washed three times with FACS buffer to remove unbound antibodies. The cells
were sorted using a BD FACS Aria cell sorter (BD Biosciences) equipped with a 100
micron nozzle and the following lasers-filters: DAPI: 405-450/50; FITC: 488-515/20;
PE/Cy7: 532-780/40; APC: 640-660/20; APC/Cy7 640-780/60. All compensation was
performed at the time of acquisition in Diva software using compensation beads
(BioLegend cat# A10497) for single color staining and SVCs for negative staining and
fluorescence (DAPI).
Single-Cell RNA-sequencing using 10x Genomics Chromium Platform:
For both mouse and human studies stromal vascular cells were isolated and flow sorted
with gating to isolate single cells away from debris, doublets, and dead cells. For the p12
pups (pooled male and female C57BL/6) and human single cell study, the cells were
further gated against CD45 to exclude leukocytes. For the adult mouse thermoneutral
(pooled male 129S6/SvEvTac) sample CD45 cells were segregated and remixed with the
SVC cells at a ratio of approximately 20% of the total cells. The sorted cells were loaded
onto a GemCode instrument (10x Genomics, Pleasanton, CA, USA) to generate singlecell barcoded droplets (GEMs) according to the manufacture’s protocol using the 10x
166

Single Cell 3’ v2 chemistry. The resulting libraries were sequenced on an Illumina
HiSeq2500 instrument with the HiSeq Rapid SBS kit. The resulting reads were aligned
and gene level unique molecular identifier (UMI) counts obtain using the Cell Ranger
(Pipeline).
The Cell Ranger Single Cell Software Suite v.2.0.1 (mouse studies) or v.3.0.1
(human studies) was used to perform sample de-multiplexing, alignment, filtering, and
UMI

counting

(https://support.10xgenomics.com/single-cell-gene-

expression/software/pipelines/latest/what-is-cell-ranger). Clustering and gene expression
were visualized with the Seurat package (version 3.0, https://satijalab.org/seurat/) on R
Studio (https://www.rstudio.com). Cells were first filtered to have > 500 detected genes
and less than 5% of total UMIs mapping to the mitochondrial genome. Clusters with very
few cells were filtered before downstream analysis. Data was scaled to mitigate the
effects of the following variables number of genes detected per cell, percent
mitochondrial reads and cell cycle phase. Dimensionality reduction was performed using
the T-stochastic Neighboring Embedding method (t-SNE) using Seurat. Differential gene
expression analysis between clusters was performed using the Seurat function
FindMarkers using the wilcox test. Violin plots, heatmap and individual tSNE plots for
the given genes were generated using the Seurat toolkit ‘VlnPlot’, ‘DoHeatmap’ and
‘FeaturePlot’ functions respectively.
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Pseudotime Analysis
Pseudotemporal analysis was performed on a filtered subset of clusters (Groups #1-4 and
Adipocytes) from the p12 pups subcutaneous SVF using the Monocle R package
(http://cole-trapnell-lab.github.io/monocle-release/). Ordering genes were selected using
a cutoff of expression in at least 10 cells and a combination of inter-cluster differential
expression and dispersion with q-value cutoff of <1e-10, which produced list of 1027
genes. A split heatmap was generated from selected genes showing significant change
through pseudotime, high differential expression, or known biologic identity using the
Monocle function ‘plot_genes_branched_heatmap’ at ‘branch_point’ 1.
RNA-Seq Library Preparation and Analysis
Subcutaneous SVCs from pooled C57BL/6 male and femalep10-16 pups were sorted as
described above into DPP4+ and ICAM1+ populations (Figure 2, GO analysis) or
DPP4+, ICAM1+, and CD142+ (Figure S10) and collected in TRIzol (Invitrogen). Total
RNA was isolated using the RNeasy Micro Kit (Qiagen). Three independent biologic
replicates were collected for each population. RNA concentration and quality were
assessed using Nanodrop2000, Qbit, and Bioanalyzer RNA 2100 (Agilent; Santa Clara,
CA). All samples had RNA integrity number (RIN) greater than 7. Library preparation
and cDNA sequencing was performed by Novogene using paired-end 150bp reads (20
million reads per sample). FASTQ files were aligned using STAR and differential gene
expression was analyzed using the R package DESeq2.
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Cell Culture and Differentiation
Mouse Studies: DPP4+, ICAM1+ and CD142+ populations were FACS-purified and
plated on Corning CellBind 384, 96, 48, or 24 well plates (Sigma-Aldrich) and cultured
in DMEM/F12 containing 10% FBS and 50 ng/mL Primocin (Invivogen, cat# ant-pm-1).
The cells were incubated for 24-48 hours to facilitate attachment prior to induction of
either adipogenic or osteogenic differentiation. For adipogenic differentiation cells were
plated at near confluence after sorting to ensure the same number of cells per well for
each cell type at the start of adipogenic induction. Adipogenic differentiation was carried
out in DMEM/F12 + 10% FBS and 50 ng/mL Primocin with the addition of either A) full
adipogenic cocktail induction (20 nM insulin, 1 nM T3, 1 M Dexamethasone (Sigma,
cat# D4902), 0.5uM Isobutylmethylxanthine (Sigma, I7018), 125 nM Indomethacin) for
2 days followed by transfer to adipogenic maintenance media (20 nM Insulin, 1 nM T3)
or B) minimal adipogenic cocktail (20 nM Insulin). Media changes were performed every
2 days and cells were analyzed for all experiments within 4-6 days of induction of
differentiation. Osteogenic differentiation was performed using the MesenCult
Osteogenic Stimulatory Kit (Stem Cell Technologies, cat#05504). Medium was changed
every 2 days and the cells were analyzed after 8 days of differentiation.

Human Studies: DPP4+, ICAM1+ and CD142+ populations were FACS-purified and
plated on Corning CellBind 384, 96, or 48 well plates (Sigma-Aldrich) and first cultured
in PM-1 media (Zenbio, cat# PM-1) supplemented with recombinant 1 nM FGF2
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(Invitrogen, PHG0261) and 50 ng/mL Primocin. Cells were plated at near confluence and
incubated for 48-72 hours to facilitate attachment prior to induction of adipogenic
differentiation. Adipogenic differentiation was carried out in DM-1 media (Zenbio, cat#
DM-1) + 3% FBS and 50 ng/mL Primocin with the addition of either A) full adipogenic
cocktail induction (20 nM insulin, 1 nM T3, 1 M Dexamethasone (Sigma, cat# D4902),
0.5uM Isobutylmethylxanthine (Sigma, I7018), 1nM Rosiglitazone maleate (Alexis
Biochemicals, 350-103-G001) for 7 days followed by transfer to adipogenic maintenance
media (20 nM Insulin, 1 nM T3) or B) minimal adipogenic cocktail (20 nM Insulin, 1nM
Rosiglitazone) throughout. Medium was changed every 7 days and the cells were
analyzed after 14-18 days of differentiation.
Mouse and Human: In some experiments, cultures were treated with 10 ng/mL of
recombinant TGFβ1 (R&D Systems, cat#240-B-002) or the TGFβ inhibitor (10 μM)
SB431552 (R&D, cat#1614) throughout differentiation. TGFβ was added at the same
time as adipogenic induction occurred while SB431552 was added to cells within 24
hours of plating. The cells were incubated in a humidified incubator at 37˚C and 5%
CO2.
Histology
Tissues were fixed with 2-4% paraformaldehyde via transcardiac perfusion, followed by
overnight fixation of dissected adipose pads. The tissues were subsequently dehydrated
through a series of ethanol washes then embedded in paraffin for thin sectioning. For
cross-sectional imaging of the inguinal adipose depots, a full-thickness section of the
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mouse flank (including the skin and adipose pad) were fixed and embedded in paraffin,
then rotated and sectioned in the cross-sectional orientation. Immunohistochemistry was
performed following heat antigen retrieval methods and stained with the following
antibodies: anti-RFP (rabbit, Rockland 1:500), anti-DPP4 (goat, R&D 1:250), anti-Pref1
(rabbit R&D), anti-Anxa3 (rabbit, Biorbyt), anti-Pi16 (rabbit, mybiosource).
Transplantation
DPP4+, ICAM1+ and CD142+ populations were purified by FACS from the
subcutaneous adipose of pooled male and female p10-p16 ROSAmT/mG pups (donor cells).
mTomato+ donor cells were washed with FACS buffer twice, then concentrated by
centrifugation. ~50,000 cells were mixed 1:1 with Matrigel (Phenol Free & Growth
Factor Reduced (GFR), Corning) on ice. Wild type C57BL/6 mouse pups age 8-12 days
were anesthetized using an isoflurane nosecone, abdominal hair was chemically removed
prior to creation of an approximately 5 mm midline Y-shaped cutaneous incision to
expose the bilateral inguinal adipose pads. Donor cell/Matrigel slurry was injected along
the edge of the inguinal fat pad in several depots. The recipient animals were closed with
6-0 polypropylene suture and placed back with their litter. After the indicated time, donor
cells were harvested from the recipient animals by dissection of the entire inguinal
adipose pad, followed by the FACS procedures as described above. Biological replicates
here mean separate pools of donor cells transplanted into separate individual recipient
mice.
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Quantification of adipocyte differentiation and cell proliferation
Adipogenesis was assessed by Biodipy 493/503 (Invitrogen, cat#D3922) staining for
lipid droplet accumulation and Hoechst 33342 (Thermo Fisher, cat#62249) staining for
nuclei number at 4-6 days post induction (mouse) and 14-18 days post induction (human)
in individual wells of a 384 well plate (Sigma-Aldrich, cat# CLS3770). The cells were
imaged on a Keyence inverted fluorescent microscope (BZX-710) using DAPI (Ex
360/40, Em 460/50, Keyence, OP-87762) and GFP (Ex 470/40, Em 525/50, Keyence,
OP-87763) filters. Individual wells were imaged in their entirety at 20x to capture a 7x7
tiled/stitched grid (mouse studies) or at 10x to capture a 5x5 tiled/stitched grid (human
studies).
Image Calculations: Tiling and stitching was performed with Keyence BZ-X
Viewer Software. Image quantification was performed in ImageJ as shown in Fig. S23.
Images were split into component channels. Nuclei (blue channel) were quantified by
applying Gaussian Blur (3 Sigma), thresholding, watershed calculation for segmentation,
and counting. Lipid accumulation was quantified by applying Gaussian Blur (2 Sigma),
thresholding, and quantification of total area above threshold. The level of adipogenesis,
called Adipogenic Index, was assessed by dividing total lipid area by total number of
nuclei and represents a number with arbitrary units for comparing absolute levels of
adipogenesis. Relative adipogenesis was calculated as the ratio of the adipogenic index in
treatment/control samples; here the control is the untreated sample from the same cell
type and biological replicate (e.x. ICAM1+ TGFβ Biological Replicate A / ICAM1+
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Control Biological Replicate A). This represents a number with arbitrary units for
comparing fold induction or suppression compared to baseline.
Statistics: All image calculations were first performed on a per well basis with the
same thresholds applied to all wells within a single experiment. Once thresholds were
determined, calculations were performed on all images in an automated manner. The
adipogenic index for biological replicates was calculated by averaging the results from
multiple technical replicates (2-8 wells per cell type, per treatment, per biological
replicate). Here independent wells (i.e. derived from the same biological and FACS pool
but plated into separate wells of the same plate) are considered technical replicates.
Statistical testing was performed on biological replicates.
Cellular proliferation was assessed by plating FACS isolated DPP4+, ICAM1+ or
CD142+ cells into a 96-well plate. For mouse studies cells were plated at 3600 cells/well
(Figure 2D), or 2000 cells/well (Figure 2H) in DMEM/F12 + 10% FBS and Primocin.
For human studies cells were plated at 5,000 cells/well in PM-1 media (Zenbio, cat# PM1) supplemented with recombinant 1 nM FGF2 (Invitrogen, PHG0261) and 50 ng/mL
Primocin. For both human and mouse studies: total nuclear content was measured for
each well using CyQuant Direct Cell Proliferation Assay (Thermo Fisher cat#C35011).
Where indicated, TGFβ1 (10ng/mL) and SB431542 (10uM) treatment were initiated after
measuring the first timepoint. Proliferation data is displayed either as a curve showing
data from independent wells from a single representative biological replicate (2D, 2H,
S15C) or as a bar graph from multiple biological replicates showing relative proliferation
rates. Relative proliferation rates were calculated for the human data in order to provide a
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comparable baseline as follows: 1) the mean slope of DPP4, ICAM1, and CD142 cells
was determined and called the “Patient Baseline”. 2) data are displayed as Cell Type
Slope/Patient Baseline. Ex (DPP4 cells Slope Patient 1) / (Average Slope of DPP4,
ICAM1, and CD142 from Patient 1).
RT- qPCR
Total RNA was isolated using the RNeasy Micro Kit (Qiagen) and quantified using a
NanoDrop. Five-hundred nanograms to 1 µg of RNA was reverse-transcribed using the
high-capacity cDNA synthesis kit (Applied Biosystems) followed by real-time PCR with
SYBR Green master mix (Applied Biosystems) on a 7900 HT machine (Applied
Biosystems). Tata-binding protein (Tbp) was used as an internal normalization control.
Data are presented as fold change relative to control. For 2 For figures 2J and 2L, data are
calculated as treatment/control where the control is the untreated sample from the same
cell type and biological replicate (e.x. ICAM1+TGFβ Biological Replicate A / ICAM1+
Control Biological Replicate A). Data were analyzed using ANOVA followed by
multiple comparisons unless otherwise indicated.
Statistical Methods
Statistical methods were not used to predetermine sample size. The experiments
were not randomized and investigators were not blinded in experiments. All p values
are reported with adjustment for multiple comparisons. Most statistical tests were
performed comparing DPP4+, ICAM1+, and CD142+ cells and therefore used an
ANOVA followed by multiple comparisons. Pairwise comparisons were determined a
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priori, were two sided, and were performed only if the ANOVA was significant, using
either the Holm-Sidak or Tukey HSD. Samples (from each human donor or pool of mice)
generates cells from all three populations (DPP4+, ICAM1+, and CD142+). Therefore, 2
Way ANOVA or Repeated Measures ANOVA were employed to account for the
matched nature of these data. For all parametric tests, QQ and residual plots were
generated to test for deviation from the ANOVA assumptions of normally distributed
residuals with equal variance. In cases with unequal variance between samples the
Brown-Forsythe correction (One Way ANOVA) or Geisser-Greenhouse correction
(Repeated Measures ANOVA) was used. Where ANOVA would be the appropriate
statistical test but the data were unbalanced, the Mixed Effects Model for statistical
testing was used instead. For Figure S14 multiple t-tests followed by Holm correction
was performed instead of ANOVA.
Where indicated, biological replicates represent independent samples; i.e. cells
derived from different human donors or from separate pools of mice. For proliferation
assays, cells from one human donor or pool of mice were plated into multiple wells, and
this was repeated across multiple individuals or pools of mice.
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